合成路线1
该中间体在本合成路线中的序号:
(V)
【1】
Belyk KM, Bender DR, Black RM,et aL 1996.Process for:preparing certain are cyclohexapeptides,US 5552521 |
【2】
Balkovec JM, Black RM, Bouffard FA 1995. Aza cyclohexapeptide conacpounds. US 5378804 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
47003 |
N-[(2R,6S,9S,11R,12R,14aS,15S,20S,23S,25aS)-20-[(1R)-3-amino-1-hydroxy-3-oxopropyl]-23-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11,12,15-tetrahydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2,1-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl]-10,12-dimethyltetradecanamide |
|
C50H80N8O17 |
详情 |
详情
|
(II) |
47005 |
N-[(2R,6S,9S,11R,12R,14aS,15S,20S,23S,25aS)-20-[(1R)-3-amino-1-hydroxypropyl]-23-[(1S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-2,11,12,15-tetrahydroxy-6-[(1R)-1-hydroxyethyl]-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2,1-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl]-10,12-dimethyltetradecanamide |
|
C50H82N8O16 |
详情 |
详情
|
(III) |
12951 |
Benzenethiol; Phenylmercaptan; Phenylhydrosulfide
|
108-98-5 |
C6H6S |
详情 | 详情
|
(IV) |
66163 |
|
|
C56H84N8O16S |
详情 | 详情
|
(V) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(A) 2) By reaction of 4-methoxybenzylamine (I) with diethyl iminocarbonate (A) in water to give diethyl N-(4-methoxybenzyl)iminocarbonate (II), followed by treatment with methylamine in water - ethanol - H2SO4.
【1】
Najer, H.; Giudidelli, J.F. (Sanofi-Synthelabo); 2-(2'-Cyclopropylphenoxymethyl)-2-imidazoline and pharmaceutically acceptable salts thereof. DE 2234714; ES 404927; FR 2145423; GB 1386355; US 3803130 .
|
【2】
Hillier, K.; Castaner, J.; Cirazoline. Drugs Fut 1978, 3, 5, 359.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(I) |
39809 |
2-cyclopropylphenol
|
10292-60-1 |
C9H10O |
详情 | 详情
|
(II) |
14443 |
2-chloroacetonitrile; chloroacetonitrile
|
107-14-2 |
C2H2ClN |
详情 | 详情
|
(III) |
39810 |
2-(2-cyclopropylphenoxy)acetonitrile
|
|
C11H11NO |
详情 |
详情
|
(IV) |
39811 |
ethyl 2-(2-cyclopropylphenoxy)ethanimidoate
|
|
C13H17NO2 |
详情 |
详情
|
(V) |
17330 |
2-(chloromethyl)-4,5-dihydro-1H-imidazole
|
|
C4H7ClN2 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(VIIII) The condensation of 4-[2-(acetylamino)ethyl]benzenesulfonyl chloride (I) with 1-cyclohexyl-2-iminoimidazolidine (III) by means of NaOH in refluxing acetone gives 1-[[4-(2-acetamidoethyl)phenyl]sulfonyl]-3-cyclohexyl-2-iminoimidazolidine (III), which is hydrolyzed with refluxing 2N HCl yielding 1-[[4-(2-aminoethyl)phenyl]sulfonyl]-3-cyclohexyl-2-iminoimidazolidine (IV). Finally, this compound is acylated with crotonic anhydride (V) in dioxane.
The starting products (I) and (II) are obtained as follows:
1) The acetylation of 2-phenylethylamine (VI) with acetic anhydride gives N-(2-phenylethyl)acetamide (VII), which is sulfonated with chlorosulfonic acid yielding compound (I).
2) The reductocondensation of cyclohexanone (IX) with ethylenediamine (VIII) gives N-cyclohexylethylenediamine (X), which is then cyclized with cyanogen chloride to compound (II).
【1】
Lehmann, C.; Dietrich, H.; Schweizer, E.H.; Marki, F.; Sulfonyliminoimidazolidines. A new clas of oral hypoglycemic agents. I. 1-[[p-[2-(Acylamino)ethyl]phenyl]sulfonyl]-2-iminoimidazolidies. J Med Chem 1983, 26, 7, 964-970.
|
【2】
Serradell, M.N.; Castaner, J.; Thorpe, P.J.; CGP-11112. Drugs Fut 1984, 9, 5, 315.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VIIII) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(I) |
34181 |
4-[2-(acetamido)ethyl]benzenesulfonyl chloride
|
|
C10H12ClNO3S |
详情 |
详情
|
(II) |
34182 |
1-cyclohexyl-2-imidazolidinimine
|
|
C9H17N3 |
详情 |
详情
|
(III) |
34183 |
N-[4-[(3-cyclohexyl-2-imino-1-imidazolidinyl)sulfonyl]phenethyl]acetamide
|
|
C19H28N4O3S |
详情 |
详情
|
(IV) |
34184 |
2-[4-[(3-cyclohexyl-2-imino-1-imidazolidinyl)sulfonyl]phenyl]-1-ethanamine; 4-[(3-cyclohexyl-2-imino-1-imidazolidinyl)sulfonyl]phenethylamine
|
|
C17H26N4O2S |
详情 |
详情
|
(V) |
34185 |
(E)-2-butenoic anhydride
|
|
C8H10O3 |
详情 |
详情
|
(VI) |
18333 |
Phenethylamine; 2-Phenyl-1-ethanamine
|
64-04-0 |
C8H11N |
详情 | 详情
|
(VII) |
34186 |
N-phenethylacetamide
|
877-95-2 |
C10H13NO |
详情 | 详情
|
(IX) |
11059 |
Cyclohexanone
|
108-94-1 |
C6H10O |
详情 | 详情
|
(X) |
34187 |
N(1)-cyclohexyl-1,2-ethanediamine; N-(2-aminoethyl)-N-cyclohexylamine
|
|
C8H18N2 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(V) This compound can be obtained by two related ways:
1) The Wittig condensation of 2-benzoylpyridine (I) with diethyl cyanomethylphosphonate (II) by means of sodium ethoxide in hot ethanol gives 3-phenyl-3-(2-pyridyl)acrylonitrite (III), which is reduced with NaBH4 in refluxing ethanol to yield 3-phenyl-3-(2-pyridyl)propionitrite (IV). Finally, this compound is cyclized with ethylenediamine (V) at reflux temperature.
2) The cyctization of 3-phenyl-3-(2-pyridyl)acrylonitrite (III) with ethylenediamine (V) at reflux temperature gives 2-[2-phenyl-2-(2-pyridyl)viny]-2-imidazoline (VI), which is then reduced with H2 over Pd/C in ethanol.
【1】
Ishikawa, F.; Cyclic guanidines. X. Synthesis of 2-(2,2-disubstituted ethenyl- and ethyl)-2-imidazolines as potent hypoglycemics. Chem Pharm Bull 1980, 28, 5, 1394-1402.
|
【2】
Castaner, J.; Hillier, K.; Blancafort, P.; Serradell, M.N.; DG-5128. Drugs Fut 1982, 7, 8, 550.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
32233 |
2-Benzoylpyridine; Phenyl(2-pyridinyl)methanone
|
91-02-1 |
C12H9NO |
详情 | 详情
|
(II) |
10045 |
Diethyl cyanomethylphosphonate
|
2537-48-6 |
C6H12NO3P |
详情 | 详情
|
(III) |
37098 |
(E)-3-phenyl-3-(2-pyridinyl)-2-propenenitrile
|
|
C14H10N2 |
详情 |
详情
|
(IV) |
37100 |
3-phenyl-3-(2-pyridinyl)propanenitrile
|
|
C14H12N2 |
详情 |
详情
|
(V) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(VI) |
37099 |
2-[(E)-2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenylethenyl]pyridine
|
|
C16H15N3 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(I) By condensation of ethylenediamine (I) with 1,2-dichloroethane (II).
【1】
Langsjoen, A.; Jones, G.D.; Zomlefer, J.; Neumann, N.M.C.; Polymerization of ethyleneimine. J Org Chem 1944, 9, 125-147.
|
【2】
Von Hoffmann, A.W.; Zur geschichte der aethylenbasen. Ber 1890, 23, 3711-18.
|
【3】
Walshe, J.M.; Dixon, H.B.F.; Gibbs, K.; Preparation of triethylenetetraamine dihydrochloride for the treatment of Wilson's disease. Lancet 1972, 1, 7755, 853.
|
【4】
Castaner, J.; Serradell, M.N.; Hopkins, S.J.; Blancafort, P.; Trientine. Drugs Fut 1983, 8, 8, 697.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(II) |
16170 |
1,2-dichloroethane
|
107-06-2 |
C2H4Cl2 |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(II) The condensation of 2-glycidyloxy-1-chlorobenzene (I) with ethylenediamine (II) in refluxing ethanol gives N-[3-(2-chlorophenoxy)-2-hydroxy propyl]ethylenediamine (III), which is then condensed with 4,5-dichloropyridazinone (IV) in refluxing ethanol.
【1】
Raabe, T.; Bohn, H.; Martorana, P.A.; Nitz R.-E. (Cassella AG); N-phenoxypropanol-N'-pyridazinyl ethylendiamines as beta -receptor blockers. DD 202013; DE 3048487; EP 54946; JP 57128677; US 4532239 .
|
【2】
Castaner, J.; Prous, J.; Ridazolol. Drugs Fut 1986, 11, 12, 1044.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
24567 |
2-[(2-chlorophenoxy)methyl]oxirane
|
|
C9H9ClO2 |
详情 |
详情
|
(II) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(III) |
24569 |
1-[(2-aminoethyl)amino]-3-(2-chlorophenoxy)-2-propanol
|
|
C11H17ClN2O2 |
详情 |
详情
|
(IV) |
24570 |
4,5-dichloro-3(2H)-pyridazinone
|
|
C4H2Cl2N2O |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(II) By condensation of 1,4,5,8-tetrahydroxyanthraquinone (I) with ethylenediamine (II) in hot tetramethylethylenediamine.
【1】
Wallace, R.E.; Durr, F.E.; Citarella, R.V.; Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones. J Med Chem 1979, 22, 9, 1024.
|
【2】
Durr, F.E.; Murdock, K.C. (American Cyanamid Co.); 1,4-Bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof. US 4197249 .
|
【3】
Castaner, J.; Arrigoni-Martelli, E.; Serradell, M.N.; CL-232468. Drugs Fut 1985, 10, 5, 376.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29310 |
1,4,5,8-tetrahydroxyanthra-9,10-quinone
|
|
C14H8O6 |
详情 |
详情
|
(II) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(V) The cyclization of catechol (I) with 2-chloroacrylonitrile (II) by means of K2CO3 in acetone gives 2-cyanobenzo-1,4-dioxane (III), which is hydrolyzed with ethanol and HCl to the corresponding iminoether (IV) Finally, this compound is cyclized with ethylenediamine (V) in cool ethanol.
【1】
Myers, P.L.; Chapleo, C.B.; 2-[2-(1,4-Benzodioxanyl)]-2-imidazoline hydrochloride. Tetrahedron Lett 1981, 22, 48, 4839-42.
|
【2】
Chapleo, C.B.; Myers, P.L. (Reckitt & Colman Pharmaceuticals); Imidazoline deriv.. GB 2068376 .
|
【3】
Hillier, K.; Idazoxan hydrochloride. Drugs Fut 1983, 8, 9, 778.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11599 |
o-Dihydroxybenzene; Catechol; Pyrocatechol
|
120-80-9 |
C6H6O2 |
详情 | 详情
|
(II) |
12372 |
2-Chloroacrylonitrile
|
920-37-6 |
C3H2ClN |
详情 | 详情
|
(III) |
36171 |
2,3-dihydro-1,4-benzodioxine-2-carbonitrile
|
|
C9H7NO2 |
详情 |
详情
|
(IV) |
36172 |
ethyl 2,3-dihydro-1,4-benzodioxine-2-carboximidoate
|
|
C11H13NO3 |
详情 |
详情
|
(V) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(A) The reaction of N-(2-chloro-4-methyl-3-thienyl)thiourea (I) with methyl iodide in methanol gives S-methyl-N-(2-chloro-4-methyl-3-thienyl)isothiouronium iodide (II), m.p. 113-5 C, which is then condensed with ethylenediamine (A) in methanol at 100 C.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(I) |
34120 |
N-(2-chloro-4-methyl-3-thienyl)thiourea
|
|
C6H7ClN2S2 |
详情 |
详情
|
(II) |
34121 |
[(2-chloro-4-methyl-3-thienyl)amino](methylsulfanyl)methaniminium iodide
|
|
C7H10ClIN2S2 |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(XIII) 6) The reaction of amine (I) with phenyl chloroformate (XI) in pyridine gives N-(5-bromoquinoxalin-6-yl)carbamic acid phenyl ester (XII), which is then treated with ethylenediamine (XIII) to afford N-(2-aminoethyl)-N'-(5-bromoquinoxalin-6-yl)urea (AGN-192170)).
【1】
Tang-Liu, D.; Burke, J.; Garst, M.; Harcourt, D.; Acheampong, A.; Breau, A.; Munk, S.A.; Wong, H.; Lai, R.; Wheeler, L.; Synthesis and characterization of degradation products and
metabolites of brimonidine - A potent alpha2 adrenergic agonist. 211th ACS Natl Meet (March 24-28, New Orleans) 1996, Abst MEDI 021. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
AGN-62989 |
62989 |
N-(2-aminoethyl)-N'-(5-bromo-6-quinoxalinyl)urea
|
|
C11H12BrN5O |
详情 |
详情
|
(I) |
10328 |
5-Bromo-6-quinoxalinamine; 5-Bromo-6-quinoxalinylamine
|
|
C8H6BrN3 |
详情 |
详情
|
(XI) |
13580 |
1-[(Chlorocarbonyl)oxy]benzene; phenyl chloroformate
|
1885-14-9 |
C7H5ClO2 |
详情 | 详情
|
(XII) |
10335 |
phenyl N-(5-bromo-6-quinoxalinyl)carbamate
|
|
C15H10BrN3O2 |
详情 |
详情
|
(XIII) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
合成路线11
该中间体在本合成路线中的序号:
(III) 4-Amino-5-chloro-2,1,3-benzothiadiazole (I) is reacted with CSCl2 to 5-chloro-4-isothiocyano-2,1,3-benzothiadiazole (II), which gives 4-[3-(2-aminoethyl)-2-thioureido]-5-chloro-2,1,3-benzothiadiazole (IV) with 1,2-diaminoethane (III). Cyclization in methanol in the presence of KOH/Pb(OAc)2 leads after 1 h at reflux to DS 103-282.
【1】
Neumann, P.; et al.; 4-(2-Imidazolin-2-ylamino)-2,1,3-benzothiadizoles. CH 579565 .
|
【2】
Becher, W.; Private Communication 2002, Abst 1520.
|
【3】
Unterhalt, B.; DS-103-282. Drugs Fut 1980, 5, 1, 27.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
32688 |
5-chloro-2,1,3-benzothiadiazol-4-amine; 5-chloro-2,1,3-benzothiadiazol-4-ylamine
|
30536-19-7 |
C6H4ClN3S |
详情 | 详情
|
(II) |
32689 |
5-chloro-4-isothiocyanato-2,1,3-benzothiadiazole; 5-chloro-2,1,3-benzothiadiazol-4-yl isothiocyanate
|
|
C7H2ClN3S2 |
详情 |
详情
|
(III) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(IV) |
32690 |
N-(2-aminoethyl)-N'-(5-chloro-2,1,3-benzothiadiazol-4-yl)thiourea
|
|
C9H10ClN5S2 |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(II) The reaction of 5-isoquinolinesulfonyl chloride (I) with ethyldiamine (II) in methylene chloride gives N-(2-aminoethyl)isoquinoline-5-sulfonamide (III), which is then condensed with S-methylisothiourea sulfate (IV) by means of NaOH at 80 C.
【1】
Asano, T.; Hidaka, H.; Vasodilatory action of HA-1004 [N-(2-guanidinoethyl)-5-isoquinolinesulfonamide], a novel calcium antagonist with no efect on cardiac function. J Pharmacol Exp Ther 1984, 231, 1, 141.
|
【2】
Koch, H.; Castaner, J.; HA-1004. Drugs Fut 1985, 10, 10, 815.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
27362 |
5-isoquinolinesulfonyl chloride
|
84468-15-5 |
C9H6ClNO2S |
详情 | 详情
|
(II) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(III) |
27363 |
N-(2-aminoethyl)-5-isoquinolinesulfonamide
|
|
C11H13N3O2S |
详情 |
详情
|
(IV) |
10272 |
[[Amino(imino)methyl]sulfanyl]methane
|
2986-19-8 |
C2H6N2S |
详情 | 详情
|
合成路线13
该中间体在本合成路线中的序号:
(A) Compound can be prepared in two different ways:
1) The condensation of 2,6-dichlorophenol (I) with alpha-bromopropionitrile (II) by means of K2CO3 in refluxing butanone gives alpha-(2,6-dichlorophenoxy)propionitrile (III), which by hydrolysis with ethanol and HCl affords ethyl ester hydrochloride (IV). Finally, this compound is cyclized with ethylenediamine (A) in ethanol at 70 C.
2) By condensation of sodium 2,6-dichlorophenolate (V) with 2-(alpha-chloroethyl)-2-imidazoline (VI) in refluxing dioxane.
【1】
Baganz, H.; May, H.J.; Imidazoline derivatives and processes for the production thereof. US 3966757 .
|
【2】
Baganz, H.; May, H.J; Nouveau procédé de préparation d'aryloxy-isoalcoyl-delta2-imidazolines et de leurs sels d'addition d'acide. CH 529766; DE 1695555; FR 1555168; GB 1181356 . |
【3】
Baganz, H.; May, H.J.; Verfahren zur Herstellung von Aryloxyisoalkyl-delta2-imidazolinen und deren Saureadditonssalzen. AT 296285B; CH 539045; DE 1935479; ES 381547 .
|
【4】
Blancafort, P.; Lofexidine. Drugs Fut 1978, 3, 8, 592.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(I) |
33574 |
2,6-dichlorophenol
|
87-65-0 |
C6H4Cl2O |
详情 | 详情
|
(II) |
33575 |
2-bromopropanenitrile
|
|
C3H4BrN |
详情 |
详情
|
(III) |
33576 |
2-(2,6-dichlorophenoxy)propanenitrile
|
|
C9H7Cl2NO |
详情 |
详情
|
(IV) |
33577 |
ethyl 2-(2,6-dichlorophenoxy)propanimidoate
|
|
C11H13Cl2NO2 |
详情 |
详情
|
(V) |
33578 |
sodium 2,6-dichlorobenzenolate
|
|
C6H3Cl2NaO |
详情 |
详情
|
(VI) |
33579 |
2-(1-chloroethyl)-4,5-dihydro-1H-imidazole
|
|
C5H9ClN2 |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(II) The cyclization of ethyl 2-(2-thienyl)glyoxylate (I) with ethylenediamine (II) in refluxing ethanol gives 3-(2-thienyl)-1,2,5,6-tetrahydropyrazin-2-one (III), which is reduced with H2 over Raney Nickel (RaNi) in hot ethanol at 50 bar.
【1】
Beyerle, R.; Bender, H.; Schindler, U.; Nitz, R.-E.; Martorana, P.A. (Cassella AG); Novel piperazinones, their preparation and use. DE 3132882; US 4598079 .
|
【2】
Tilford, C.H.; Carr, A.A. Jr.; Kuhn, W.L. (Aventis Pharmaceuticals, Inc.); Substd. 5,6-dihydro-2(1H)-pyrazinones. US 3056784 .
|
【3】
Castaner, J.; Prous, J.; Telnisetam. Drugs Fut 1988, 13, 2, 130.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
21871 |
ethyl 2-oxo-2-(2-thienyl)acetate
|
4075-58-5 |
C8H8O3S |
详情 | 详情
|
(II) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(III) |
21873 |
3-(2-thienyl)-5,6-dihydro-2(1H)-pyrazinone
|
|
C8H8N2OS |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(V) The reaction of 2-chloro-5-tritluoromethylaniline (I) with ammonium thiocyanate (II) in hot chlorobenzene gives N-(2-chloro-5-trifluoromethylphenyl)isothiourea (III), whith is cyclized with ethylenediamine (IV) in refluxing methanol.
【1】
Stahle, H.; Zeiler, K.; Koppe, H.; Wolf, M.; Hoefke, W. (Boehringer Ingelheim GmbH); Derivs. of 2-(2'-halo-anilino)1,3-diazacyclo-pentene-(2). US 3462433 .
|
【2】
Weetman, D.F.; Serradell, M.N.; Castaner, J.; Blancafort, P.; ST-587. Drugs Fut 1982, 7, 9, 653.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
37107 |
2-chloro-5-(trifluoromethyl)phenylamine; 2-chloro-5-(trifluoromethyl)aniline
|
121-50-6 |
C7H5ClF3N |
详情 | 详情
|
(II) |
37108 |
thiocyanate
|
|
CNS |
详情 |
详情
|
(III) |
37109 |
1-chloro-2-[[imino(sulfanyl)methyl]amino]-4-(trifluoromethyl)benzene
|
|
C8H6ClF3N2S |
详情 |
详情
|
(V) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
合成路线16
该中间体在本合成路线中的序号:
(IV) The cyclization of diphenyldiazomethane (I) with acrylonitrile (II) in CHCl3 gives cyano-2,2-diphenylcyclopropane (III), which is then cyclized with ethylenediamine tosylate (IV) by heating at 200 C.
【1】
Cognaco, J.-C.; 1-(2-delta(2)-Imidazolinyl)-2,2-diarylcyclopropanes and process. CA 1006526; CH 585207; DE 2359816; FR 2208663; GB 1417174; JP 49093363; NL 7316487; US 3903104 .
|
【2】
Cognaco, J.-C.; Chlorinated derivatives of 1-(2-delta(2)-imidazolinyl)-2,2-diarylcyclopropanes. CA 1018176; CH 583200; DE 2359795; FR 2208664; JP 50004072; NL 7316484; US 3905993 .
|
【3】
Neuman, M.; Blancafort, P.; Castaner, J.; Serradell, M.N.; Cibenzoline. Drugs Fut 1982, 7, 4, 239.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
31711 |
1-(2-diazo-1-phenylethyl)benzene
|
|
C14H12N2 |
详情 |
详情
|
(II) |
10847 |
Acrylonitrile
|
107-13-1 |
C3H3N |
详情 | 详情
|
(III) |
31712 |
2,2-diphenylcyclopropanecarbonitrile
|
|
C16H13N |
详情 |
详情
|
(IV) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
合成路线17
该中间体在本合成路线中的序号:
(II) The cyclization of 2-amino-4'-bromobenzophenone (I) with ethyl 2-(methylthio)acetate (II) by means of tert-butyl hypochlorite in dichloromethane at 70 C gives 7-(4-bromobenzoyl)-3-(methylthio)-2,3-dihydro-1H-indol-2-one (III), which is desulfurized by a treatment with Raney Nickel in THF yielding 7-(4-bromobenzoyl)-2,3-dihydro-1H-indol-2-one (IV). Finally, this compound is hydrolyzed with refluxing 3N NaOH and acidified with concentrated HCl.
【1】
York, B.M. Jr. (Alcon Laboratories, Inc.); Method for lowering intraocular pressure using phenylimino-imidazoles. US 4517199 .
|
【2】
Cavero, I.; Langer, S.Z.; York, B.M. Jr.; Method of lowering intraocular pressure using phenylimino-imidazoles. US 4515800 .
|
【3】
Prous, J.; Castaner, J.; Aplonidine hydrochloride. Drugs Fut 1988, 13, 6, 507.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22592 |
2,6-dichloro-4-nitrophenylamine; 2,6-dichloro-4-nitroaniline
|
99-30-9 |
C6H4Cl2N2O2 |
详情 | 详情
|
(II) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(II) |
22593 |
2,6-dichloro-1,4-benzenediamine; 4-amino-2,6-dichlorophenylamine
|
609-20-1 |
C6H6Cl2N2 |
详情 | 详情
|
(III) |
22594 |
N-(4-amino-3,5-dichlorophenyl)-2,2,2-trichloroacetamide
|
|
C8H5Cl5N2O |
详情 |
详情
|
(IV) |
22595 |
2,2,2-trichloro-N-[3,5-dichloro-4-(formylamino)phenyl]acetamide
|
|
C9H5Cl5N2O2 |
详情 |
详情
|
(V) |
22596 |
1,3-dichloro-2-[(dichloromethylene)amino]-5-[(2,2,2-trichloroacetyl)amino]benzene
|
|
C9H3Cl7N2O |
详情 |
详情
|
(VII) |
22597 |
2,2,2-trichloro-N-[3,5-dichloro-4-(2-imidazolidinylideneamino)phenyl]acetamide
|
|
C11H9Cl5N4O |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(XI) The condensation of 2-hydroxybenzaldehyde (I) with ethyl 2-bromobutyrate (II) by means of K2CO3 and NaI in DMF gives ethyl-2-(2-formylphenoxy) butyrate (III), which is reduced with NaBH4 and NaOEt in ethanol yielding the hydroxymethyl derivative (IV). The reaction of (IV) with SOCl2 affords the corresponding chloromethyl compound (V), which is cyclized by means of NaH in N-methylpyrrolidone to give 2-ethyl-2,3-dihydrobenzofuran-2-carboxylic acid ethyl ester (VI). The hydrolysis of the ethyl ester of (VI) with NaOH in methanol yields the expected carboxylic acid (VII), which is treated with SOCl2 and then with NH3 to afford the amide (VIII). This compound can also be obtained directly from ester (VI) by reaction with NH3. The dehydration of (VIII) by means of P2O5 or POCl3 gives the nitrile (IX), which is treated with HCl in ethanol yielding the carboxyimidate (X). Finally, this compound is cyclized with ethylenediamine (XI) in ethanol.
【1】
Edwards, C.R.; et al.; A practical synthesis of 2,3-dihydro-2-benzofurancarboxylic acid: A general route to 2,3-dihydrobenzofurans. J Heterocycl Chem 1987, 24, 495.
|
【2】
Chapleo, C.B.; et al.; alpha-Adrenoceptor reagents. 2. Effects of modification of the 1,4-benzodioxan ring system on alpha-adrenoreceptor activity. J Med Chem 1984, 27, 5, 570-6.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
21351 |
2-Hydroxybenzaldehyde;Salicylic aldehyde;2-Formylphenol;salicylaldehyde |
90-02-8 |
C7H6O2 |
详情 | 详情
|
(II) |
36668 |
ethyl 2-bromobutanoate
|
533-68-6 |
C6H11BrO2 |
详情 | 详情
|
(III) |
36669 |
ethyl 2-(2-formylphenoxy)butanoate
|
|
C13H16O4 |
详情 |
详情
|
(IV) |
36670 |
ethyl 2-[2-(hydroxymethyl)phenoxy]butanoate
|
|
C13H18O4 |
详情 |
详情
|
(V) |
36671 |
ethyl 2-[2-(chloromethyl)phenoxy]butanoate
|
|
C13H17ClO3 |
详情 |
详情
|
(VI) |
36672 |
ethyl 2-ethyl-2,3-dihydro-1-benzofuran-2-carboxylate
|
|
C13H16O3 |
详情 |
详情
|
(VII) |
36673 |
2-ethyl-2,3-dihydro-1-benzofuran-2-carboxylic acid
|
|
C11H12O3 |
详情 |
详情
|
(VIII) |
36674 |
2-ethyl-2,3-dihydro-1-benzofuran-2-carboxamide
|
|
C11H13NO2 |
详情 |
详情
|
(IX) |
36675 |
2-ethyl-2,3-dihydro-1-benzofuran-2-carbonitrile
|
|
C11H11NO |
详情 |
详情
|
(X) |
36676 |
ethyl 2-ethyl-2,3-dihydro-1-benzofuran-2-carboximidoate
|
|
C13H17NO2 |
详情 |
详情
|
(XI) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
合成路线19
该中间体在本合成路线中的序号:
(XI) The condensation of 2-fluorobenzylmagnesium bromide (XII) with 2-oxobutyric acid ethyl ester (XIII) in ethyl ether gives 2-(2-fluorobenzyl)-2-hydroxybutyric acid ethyl ester (XIV), which is cyclized by means of NaH in toluene/DMF yielding he ester (VI). The hydrolysis of (VI) with NaOH affords the acid (VII), which is treated with SOCl2 to give the acyl chloride (XV). Then this compound is cyclized with ethylenediamine (XI) by means of AlMe3 in refluxing toluene.
The reaction of 2-fluorobenzaldehyde (XVI) with ethyl 2-bromobutyrate (II) by means of potassium tert-butoxide in dioxane gives the epoxide (XVII), which is opened by hydrogenation with H2 over Pd/C in ethanol to afford the previously reported hydroxybutyric ester (XIV).
The condensation of 2-fluorophenyllithium (XVIII) or 2-fluorophenylmagnesium bromide (XIX) with 2-(benzyloxymethyl)-2-ethyloxirane (XX) gives 1-(benzyloxy)-2-ethyl-3-(2-fluorophenyl)-2-propanol (XXI), which is cyclized by means of NaH yielding 2-(benzyloxymethyl)-2-ethyl-2,3-dihydrobenzofuran (XXII). Finally, this compound is debenzylated with H2 over Pd/C and oxidized with CrO3 and sulfuric acid to afford the previously reported carboxylic acid (VII).
The alkylation of 2,3-dihydrobenzofuran-2-carboxylic acid (XXIII) with ethyl iodide by means of lithium diisopropylamide gives the previously reported carboxylic acid (VII).
【1】
Couture, K.; et al.; A new approach to the synthesis of efaroxan. Bioorg Med Chem Lett 1999, 9, 20, 3023.
|
【2】
Mayer, P.; et al.; A new efficient synthesis of efaroxan. Bioorg Med Chem Lett 1999, 9, 20, 3021.
|
【3】
Chapleo, C.B.; et al.; alpha-Adrenoceptor reagents. 2. Effects of modification of the 1,4-benzodioxan ring system on alpha-adrenoreceptor activity. J Med Chem 1984, 27, 5, 570-6.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
36668 |
ethyl 2-bromobutanoate
|
533-68-6 |
C6H11BrO2 |
详情 | 详情
|
(VI) |
36672 |
ethyl 2-ethyl-2,3-dihydro-1-benzofuran-2-carboxylate
|
|
C13H16O3 |
详情 |
详情
|
(VII) |
36673 |
2-ethyl-2,3-dihydro-1-benzofuran-2-carboxylic acid
|
|
C11H12O3 |
详情 |
详情
|
(XI) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(XII) |
36688 |
bromo(2-fluorobenzyl)magnesium
|
|
C7H6BrFMg |
详情 |
详情
|
(XIII) |
36677 |
ethyl 2-oxobutanoate
|
|
C6H10O3 |
详情 |
详情
|
(XIV) |
36678 |
ethyl 2-(2-fluorobenzyl)-2-hydroxybutanoate
|
|
C13H17FO3 |
详情 |
详情
|
(XV) |
36682 |
2-ethyl-2,3-dihydro-1-benzofuran-2-carbonyl chloride
|
|
C11H11ClO2 |
详情 |
详情
|
(XVI) |
36679 |
2-fluorobenzaldehyde
|
446-52-6 |
C7H5FO |
详情 | 详情
|
(XVII) |
36680 |
ethyl 2-ethyl-3-(2-fluorophenyl)-2-oxiranecarboxylate
|
|
C13H15FO3 |
详情 |
详情
|
(XVIII) |
36683 |
(2-fluorophenyl)lithium
|
|
C6H4FLi |
详情 |
详情
|
(XIX) |
36684 |
bromo(2-fluorophenyl)magnesium
|
|
C6H4BrFMg |
详情 |
详情
|
(XX) |
36685 |
benzyl (2-ethyl-2-oxiranyl)methyl ether; 2-[(benzyloxy)methyl]-2-ethyloxirane
|
|
C12H16O2 |
详情 |
详情
|
(XXI) |
36686 |
1-(benzyloxy)-2-(2-fluorobenzyl)-2-butanol
|
|
C18H21FO2 |
详情 |
详情
|
(XXII) |
36687 |
2-[(benzyloxy)methyl]-2-ethyl-2,3-dihydro-1-benzofuran; benzyl (2-ethyl-2,3-dihydro-1-benzofuran-2-yl)methyl ether
|
|
C18H20O2 |
详情 |
详情
|
(XXIII) |
36681 |
2,3-dihydro-1-benzofuran-2-carboxylic acid
|
|
C9H8O3 |
详情 |
详情
|
合成路线20
该中间体在本合成路线中的序号:
(II) The condensation of pyridoxal 5-phosphate (I) with ethylenediamine (II) in methanol by means of NaOH gives the corresponding diimine (III), which is reduced with hydrogen over Pt/C in methanol/water yielding the expected diamine (IV). The reaction of (IV) with bromoacetic acid (V) by means of NaOH in methanol/water affords the N,N'-diacetic acid derivative (VI), which is finally treated with MnCl2 in water containing NaOH.
【1】
Rocklage, S.M.; Cacheris, W.P.; Quay, S.C.; Hahn, F.E.; Raymond, K.N.; Manganese(II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate). Synthesis and characterization of a paramagnetic chelate for magnetic resonance imaging enhancement. Inorg Chem 1989, 28, 477-85. |
【2】
Graul, A.; Leeson, P.; Castaner, J.; Mangafodipir Trisodium. Drugs Fut 1997, 22, 9, 974.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14753 |
Pyridoxal 5'-phosphate; (4-formyl-5-hydroxy-6-methyl-3-pyridinyl)methyl dihydrogen phosphate
|
54-47-7 |
C8H10NO6P |
详情 | 详情
|
(II) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(III) |
14759 |
[5-hydroxy-4-[([2-[((E)-[3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinyl]methylidene)amino]ethyl]imino)methyl]-6-methyl-3-pyridinyl]methyl dihydrogen phosphate
|
|
C18H24N4O10P2 |
详情 |
详情
|
(IV) |
14756 |
[5-hydroxy-4-[([2-[([3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinyl]methyl)amino]ethyl]amino)methyl]-6-methyl-3-pyridinyl]methyl dihydrogen phosphate
|
|
C18H28N4O10P2 |
详情 |
详情
|
(V) |
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(VI) |
14758 |
2-[[2-[(carboxymethyl)([3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinyl]methyl)amino]ethyl]([3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]-4-pyridinyl]methyl)amino]acetic acid
|
|
C22H32N4O14P2 |
详情 |
详情
|
合成路线21
该中间体在本合成路线中的序号:
(IX) Morpholine (VI) was treated with carbonyl diimidazole (VII), and the resulting imidazolide (VIII) was further condensed with ethylenediamine (IX) to give urea (X). Reaction of epoxide (V) with amine (X) furnished the title compound.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
48334 |
[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-[4-[(2S)oxiranylmethoxy]phenyl]propanoate
|
|
C18H24O6 |
详情 |
详情
|
(VI) |
10388 |
Morpholine
|
110-91-8 |
C4H9NO |
详情 | 详情
|
(VII) |
11353 |
1,1'-Carbonyldiimidazole; Di(1H-imidazol-1-yl)methanone; N,N-Carbonyldiimidazole; 1,1'-Carbonylbis(1H-imidazole)
|
530-62-1 |
C7H6N4O |
详情 | 详情
|
(VIII) |
48336 |
1H-imidazol-1-yl(4-morpholinyl)methanone
|
|
C8H11N3O2 |
详情 |
详情
|
(IX) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(X) |
32153 |
N-(2-aminoethyl)-4-morpholinecarboxamide; 4-[N-(2-Aminoethyl)carbamoyl]morpholine
|
|
C7H15N3O2 |
详情 |
详情
|
合成路线22
该中间体在本合成路线中的序号:
(II) The condensation of tert-butoxycarbonyl-D-alanine (I) with ethylenediamine (II) gives the corresponding protected diamide (III), which is deprotected in acidic medium to the diamide (IV). The reduction of (IV) with diborane in THF yields the (R,R)-4,7-diazadecane-2,9-diamine (V), which is finally condensed with 3-nitronaphthalene-1,8-dicarboxylic acid anhydride (VI) in refluxing ethanol and salified with methanesulfonic acid.
【1】
Robinson, C.P.; Robinson, K.A.; Castaner, J.; Bisnafide Mesylate. Drugs Fut 1996, 21, 3, 239.
|
【2】
Sun, J.-H. (DuPont Pharmaceuticals Co.); Bis-naphthalimides containing amino-acid derived linkers as anticancer agents. EP 0506008; EP 0577753; JP 1994506229; US 5206249; WO 9217453 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15859 |
Boc-D-Alanine; (2R)-2-[(tert-butoxycarbonyl)amino]propionic acid
|
7764-95-6 |
C8H15NO4 |
详情 | 详情
|
(II) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(III) |
15861 |
tert-butyl N-[(1R,8R)-1,8,12,12-tetramethyl-2,7,10-trioxo-11-oxa-3,6,9-triazatridec-1-yl]carbamate
|
|
C18H34N4O6 |
详情 |
详情
|
(IV) |
15862 |
(2R)-2-amino-N-(2-[[(2R)-2-aminopropanoyl]amino]ethyl)propanamide
|
|
C8H18N4O2 |
详情 |
详情
|
(V) |
15863 |
(2R)-N(1)-(2-[[(2R)-2-aminopropyl]amino]ethyl)-1,2-propanediamine; N-[(2R)-2-aminopropyl]-N-(2-[[(2R)-2-aminopropyl]amino]ethyl)amine
|
|
C8H22N4 |
详情 |
详情
|
(VI) |
15864 |
5-nitro-1H,3H-benzo[de]isochromene-1,3-dione; 3-Nitro-1,8-naphthalic anhydride
|
3027-38-1 |
C12H5NO5 |
详情 | 详情
|
合成路线23
该中间体在本合成路线中的序号:
(VII) 3,4-Pyridinedicarboxylic acid (I) was converted to the cyclic anhydride (II) upon heating with acetic anhydride. Friedel-Crafts condensation of anhydride (II) with p-difluorobenzene (III) in the presence of AlCl3 gave rise to a mixture of two regioisomeric keto acids, (IV) and (V). Cyclization of this mixture in fuming sulfuric acid at 140 C generated the benzoisoquinoline (VI) (1,2). Subsequent displacement of the fluorine atoms of (VI) with ethylenediamine (VII) in pyridine provided the target bis(2-aminoethylamino) derivative, which was finally converted to the stable dimaleate salt. Alternatively, ethylenediamine (VII) was protected as the mono-N-Boc derivative (VIII) by treatment with Boc2O. Condensation of the difluoro compound (VI) with the protected ethylenediamine (VIII) furnished (IX). The Boc groups of (IX) were then removed by treatment with trifluoroacetic acid. After adjustment of the pH to 4.2 with KOH, treatment with maleic acid provided BBR-2778.
【1】
Spinelli, S.; DiDomenico, R. (Roche Diagnostics GmbH); 6,9-Bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5, 10-dione and its dimaleate salt. JP 1997507674; JP 2001089454; US 5506232; WO 9526189 .
|
【2】
Krapcho, P.A. (University of Vermont); 6,9-Bis(substd.-amino)benzo-[g]isoquinoline-5,10-diones. EP 0503537; EP 0575526; JP 1994511230; WO 9215300 .
|
【3】
Krapcho, A.P.; et al.; 6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5, 10-diones. A novel class of chromophore-modified antitumor anthracene-9,10-diones: Synthesis and antitumor evaluations. J Med Chem 1994, 37, 6, 828.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
52805 |
3,4-Pyridinedicarboxylic acid; Cinchomeronic acid; Pyridin-3,4-dicarboxylic acid; Pyridine-3,4-dicarboxylic acid
|
490-11-9 |
C7H5NO4 |
详情 | 详情
|
(II) |
52806 |
3,4-Pyridine dicarboxylic anhydride; Pyridine-3,4-dicarboxylic anhydride
|
4664-08-8 |
C7H3NO3 |
详情 | 详情
|
(III) |
52807 |
1,4-Difluorobenzene; p-Difluorobenzene
|
540-36-3 |
C6H4F2 |
详情 | 详情
|
(IV) |
52808 |
4-(2,5-difluorobenzoyl)nicotinic acid
|
|
C13H7F2NO3 |
详情 |
详情
|
(V) |
52809 |
3-(2,5-difluorobenzoyl)isonicotinic acid
|
|
C13H7F2NO3 |
详情 |
详情
|
(VI) |
52810 |
6,9-difluorobenzo[g]isoquinoline-5,10-dione
|
|
C13H5F2NO2 |
详情 |
详情
|
(VII) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(VIII) |
13241 |
N-Boc-ethylenediamine;tert-butyl (2-aminoethyl)carbamate;tert-butyl 2-aminoethylcarbamate; tert-Butyl n-(2-aminoethyl)carbamate |
57260-73-8 |
C7H16N2O2 |
详情 | 详情
|
(IX) |
52811 |
tert-butyl 2-{[6-({2-[(tert-butoxycarbonyl)amino]ethyl}amino)-5,10-dioxo-5,10-dihydrobenzo[g]isoquinolin-9-yl]amino}ethylcarbamate
|
|
C27H35N5O6 |
详情 |
详情
|
合成路线24
该中间体在本合成路线中的序号:
(VIIII) Friedel-Crafts bis-acylation of p-dimethoxybenzene (X) with anhydride (II) in molten aluminum chloride/sodium chloride afforded the benzoisoquinoline (XI). This compound was reduced with sodium dithionite to generate an intermediate leuco form (XII). Subsequent addition of Boc-ethylenediamine (VIII) to (XII) produced, after air oxidation during the work-up, the protected tetraamino compound (IX). Alternatively, addition of ethylenediamine (VII) to the intermediate (XII) led to the free base of BBR-2778, which was converted to the maleate.
【1】
Krapcho, A.P.; et al.; 6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5, 10-diones. A novel class of chromophore-modified antitumor anthracene-9,10-diones: Synthesis and antitumor evaluations. J Med Chem 1994, 37, 6, 828.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VIIII) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(II) |
52806 |
3,4-Pyridine dicarboxylic anhydride; Pyridine-3,4-dicarboxylic anhydride
|
4664-08-8 |
C7H3NO3 |
详情 | 详情
|
(VII) |
13241 |
N-Boc-ethylenediamine;tert-butyl (2-aminoethyl)carbamate;tert-butyl 2-aminoethylcarbamate; tert-Butyl n-(2-aminoethyl)carbamate |
57260-73-8 |
C7H16N2O2 |
详情 | 详情
|
(IX) |
52811 |
tert-butyl 2-{[6-({2-[(tert-butoxycarbonyl)amino]ethyl}amino)-5,10-dioxo-5,10-dihydrobenzo[g]isoquinolin-9-yl]amino}ethylcarbamate
|
|
C27H35N5O6 |
详情 |
详情
|
(X) |
21946 |
1,4-dimethoxybenzene; 4-methoxyphenyl methyl ether
|
150-78-7 |
C8H10O2 |
详情 | 详情
|
(XI) |
52812 |
6,9-dihydroxybenzo[g]isoquinoline-5,10-dione
|
|
C13H7NO4 |
详情 |
详情
|
(XII) |
52813 |
5,10-dihydroxy-7,8-dihydrobenzo[g]isoquinoline-6,9-dione
|
|
C13H9NO4 |
详情 |
详情
|
合成路线25
该中间体在本合成路线中的序号:
(IV) The cyclization of 9-fluoro-6-(tosyloxy)-5,10-dihydrobenzo[g]isoquinoline-5,10-dione (I) with 2-(dimethylamino)ethylhydrazine (II) gives 2-[2-(dimethylamino)ethyl]-5-(tosyloxy)indazolo[4,3-gh]isoquinolin-6(2H)-one (III), which is finally condensed with ethylene-1,2-diamine (IV) to afford the title compound.
【1】
Gallagher, C.E.; Maresch, M.J.; Krapcho, A.P.; et al.; 6,9-Disubstituted benz[g]isoquinoline-5,10-diones, key intermediates for the synthesis of antitumor 2,5-disubstituted-indazolo[4,3-gh]isoquinoline-6(2H)-ones (9-aza-anthrapyrazoles). 25th Natl Med Chem Symp (June 18, Univ. Michigan, Ann Arbor) 1996, Abst. 15. |
【2】
Krapcho, A.P.; Menta, E.; Antitumor aza-anthrapyrazoles. Drugs Fut 1997, 22, 6, 641.
|
【3】
Menta, E.; et al.; Synthesis and antitumor evalution of 2, 5-disubstituted-indazolo[4, 3-gh]isoquinoline-6(2H)-ones (9-aza-anthrapyrazoles). 211th ACS Natl Meet (March 24-28, New Orleans) 1996, Abst MEDI 076.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
41185 |
9-fluoro-5,10-dioxo-5,10-dihydrobenzo[g]isoquinolin-6-yl 4-methylbenzenesulfonate
|
|
C20H12FNO5S |
详情 |
详情
|
(II) |
41186 |
N-(2-hydrazinoethyl)-N,N-dimethylamine; 2-hydrazino-N,N-dimethyl-1-ethanamine
|
|
C4H13N3 |
详情 |
详情
|
(III) |
41187 |
2-[2-(dimethylamino)ethyl]-6-oxo-2,6-dihydroindazolo[4,3-gh]isoquinolin-5-yl 4-methylbenzenesulfonate
|
|
C24H22N4O4S |
详情 |
详情
|
(IV) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
合成路线26
该中间体在本合成路线中的序号:
Condensation of N,N'-dibenzylethylenediamine (I) with ethyl 2,3-dibromopropionate (II) in the presence of Et3N in toluene at 80 C gave, after acidification, piperazine (III). Then, hydrogenolytic N-debenzylation in the presence of Pd/C provided ethyl piperazine-2-carboxylate (IV), which was selectively alkylated at position 4 with 1 equivalent of triphenylmethyl chloride in the presence of Et3N at -10 C to give (V). Subsequent alkylation with 2,4-dichlorobenzyl chloride (VI) in the presence of K2CO3 and a catalytic amount of KI provided (VII). Removal of the N-trityl group by treatment with HCl in either acetone or ethanol afforded piperarine (VIII), which was N-methylated by reaction with formaldehyde and formic acid in refluxing MeOH. Finally, the resulting compound (IX) was converted into the imidazoline on treatment with ethylenediamine and trimethylaluminum in refluxing toluene.
【1】
Rondu, F.; et al.; Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 1. Synthesis and biological activities of N-benzyl-N'-(arylalkyl)-2-(4', 5'-dihydro-1'H-imidazol-2'-yl)piperazines. J Med Chem 1997, 40, 23, 3793. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(I) |
18340 |
N(1),N(2)-dibenzyl-1,2-ethanediamine; N-benzyl-N-[2-(benzylamino)ethyl]amine; N,N-Dibenzylethylendiamine
|
140-28-3 |
C16H20N2 |
详情 | 详情
|
(II) |
18341 |
ethyl 2,3-dibromopropanoate
|
3674-13-3 |
C5H8Br2O2 |
详情 | 详情
|
(III) |
18342 |
ethyl 1,4-dibenzyl-2-piperazinecarboxylate
|
72351-59-8 |
C21H26N2O2 |
详情 | 详情
|
(IV) |
18343 |
ethyl 2-piperazinecarboxylate
|
89941-07-1 |
C7H14N2O2 |
详情 | 详情
|
(V) |
18344 |
ethyl 4-trityl-2-piperazinecarboxylate
|
|
C26H28N2O2 |
详情 |
详情
|
(VI) |
18345 |
2,4-Dichlorobenzyl chloride; 2,4-Dichloro-1-(chloromethyl)benzene
|
94-99-5 |
C7H5Cl3 |
详情 | 详情
|
(VII) |
18346 |
ethyl 1-(2,4-dichlorobenzyl)-4-trityl-2-piperazinecarboxylate
|
|
C33H32Cl2N2O2 |
详情 |
详情
|
(VIII) |
18347 |
ethyl 1-(2,4-dichlorobenzyl)-2-piperazinecarboxylate
|
|
C14H18Cl2N2O2 |
详情 |
详情
|
(IX) |
18348 |
ethyl 1-(2,4-dichlorobenzyl)-4-methyl-2-piperazinecarboxylate
|
|
C15H20Cl2N2O2 |
详情 |
详情
|
合成路线27
该中间体在本合成路线中的序号:
(II) The amidation of L-serine methyl ester (I) with ethylenediamine (II) gives the amide (III), which is reduced with borane/THF to 2(R)-(hydroxymethyl)diethylenetriamine (IV). The reaction of (IV) with bromoacetic acid tert-butyl ester (V) by means of DIEA in DMF affords the penta tert-butyl acetate (VI), which is condensed with the chlorophosphoramidite (VII) by means of DIEA in dichloromethane giving the phosphoramidite intermediate (VIII). The condensation of (VIII) with 4,4-diphenylcyclohexanol (IX) (see scheme 23537901b) by means of tetrazole in acetonitile, with simultaneous oxidation with tert-butyl hydroperoxide yields the phosphate (X), which is selectively hydrolyzed at the 2-cyanoethyl ester group with ammonia in methanol affording the ammonium phosphate (XI). Finally, the hydrolysis of (XI) with HCl in ether/water eliminates the tert-butyl groups affording the desired chelating ligand (XII)
【1】
Scott, D.M.; Sajiki, H.; McMurray, T.J.; Lauffer, R.B. (Epix Medical, Inc.); Diagnostic imaging contrast agents with extended blood retention. WO 9623526 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20915 |
methyl (2S)-2-amino-3-hydroxypropanoate
|
5680-80-8 |
C4H9NO3 |
详情 | 详情
|
(II) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(III) |
30315 |
(2S)-2-amino-N-(2-aminoethyl)-3-hydroxypropanamide
|
|
C5H13N3O2 |
详情 |
详情
|
(IV) |
30316 |
(2R)-2-amino-3-[(2-aminoethyl)amino]-1-propanol
|
|
C5H15N3O |
详情 |
详情
|
(V) |
17430 |
2-Bromoacetic acid tert-butyl ester; tert-butyl 2-bromoacetate; tert-Butyl bromoacetate
|
5292-43-3 |
C6H11BrO2 |
详情 | 详情
|
(VI) |
30317 |
3,6,9-Tris(tert-butoxycarbonylmethyl)-4(R)-(hydroxymethyl)-3,6,9-triazaundecanedioic acid di-tert-butyl ester
|
|
C35H65N3O11 |
详情 |
详情
|
(VII) |
22791 |
2-Cyanoethyl N,N-diisopropylphosphoramidochloridite
|
89992-70-1 |
C9H18ClN2OP |
详情 | 详情
|
(VIII) |
30318 |
3,6,9-Tris(tert-butoxycarbonylmethyl)-4(R)-[2-cyanoethoxy(diisopropylamino)phosphinyloxymethyl]-3,6,9-triazaundecanedioic acid di-tert-butyl ester
|
|
C44H82N5O12P |
详情 |
详情
|
(IX) |
30319 |
4,4-diphenylcyclohexanol
|
|
C18H20O |
详情 |
详情
|
(X) |
30320 |
3,6,9-Tris(tert-butoxycarbonylmethyl)-4(R)-[2-cyanoethoxy(4,4-diphenylcyclohexyloxy)phosphoryloxymethyl]-3,6,9-triazaundecanedioic acid di-tert-butyl ester
|
|
C56H87N4O14P |
详情 |
详情
|
(XI) |
30321 |
3,6,9-Tris(tert-butoxycarbonylmethyl)-4(R)-[4,4-diphenylcyclohexyloxy(hydroxy)phosphoryloxymethyl]-3,6,9-triazaundecanedioic acid di-tert-butyl ester ammonium salt
|
|
C53H87N4O14P |
详情 |
详情
|
(XII) |
30322 |
3,6,9-Tris(carboxymethyl)-4(R)-[4,4-diphenylcyclohexyloxy(hydroxy)phosphoryloxymethyl]-3,6,9-triazaundecanedioic acid
|
|
C33H44N3O14P |
详情 |
详情
|
合成路线28
该中间体在本合成路线中的序号:
(IV) Alkylation of ethyl piperazine-2-carboxylate (I) with two equivalents of isopropyl iodide (II) afforded disubstituted piperazine (III). The title imidazoline was then obtained by reaction of the ester function of (III) with ethylenediamine (IV) in the presence of trimethylaluminum.
【1】
Le Bihan, G.; et al.; Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 2. Syntheses and biological activities of 1,4-dialkyl-, 1,4-dibenzyl, and 1-benzyl-4-alkyl-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines an. J Med Chem 1999, 42, 9, 1587. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18343 |
ethyl 2-piperazinecarboxylate
|
89941-07-1 |
C7H14N2O2 |
详情 | 详情
|
(II) |
19369 |
2-iodopropane
|
75-30-9 |
C3H7I |
详情 | 详情
|
(III) |
24419 |
ethyl 1,4-diisopropyl-2-piperazinecarboxylate
|
|
C13H26N2O2 |
详情 |
详情
|
(IV) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
合成路线29
该中间体在本合成路线中的序号:
(I) The reaction of ethylenediamine (I) with Boc2O in dioxane gives the monocarbamate (II), which is condensed with O-methylisourea (III) to yield the aminoguanidine carbamate (IV). The cleavage of the carbamate group of (IV) by means of HCl in methanol affords the aminoguanidine (V), which is condensed with 1-methyl-4-nitropyrrole-2-carbonyl chloride (VI) by means of NaHCO3 in dioxane/water to provide the amide (VII). The reduction of the nitro group of (VII) by means of H2 over Pd/C in 1N HCl affords the 4-aminopyrrole-2-carboxamide (VIII), which is condensed with the acid chloride (VI) as before to give the diamide (IX). Reduction of the nitro group of (IX) under the same conditions described above yields the amino diamide (X), which is condensed with the 14-labeled acid chloride (XI) as described above to afford the triamide (XII). Further reduction of the nitro group of (XII) gives the amino triamide (XIII), which is finally condensed with 4-(2-bromopropenamido)-1-methylpyrrole-2-carbonyl chloride (XIV) by means of NaHCO3 in dioxane/water to yield the target 14C labeled pentaamide compound.
【1】
Fontana, E.; Pignatti, A.; Synthesis of brostallicin (PNU-166196A) labelled with 2H and 14C. Label. Cop. & Radiopharm. 2002, 45, 11, 899.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(II) |
13241 |
N-Boc-ethylenediamine;tert-butyl (2-aminoethyl)carbamate;tert-butyl 2-aminoethylcarbamate; tert-Butyl n-(2-aminoethyl)carbamate |
57260-73-8 |
C7H16N2O2 |
详情 | 详情
|
(III) |
26657 |
O-methyl isourea; [Amino(imino)methoxy]methane
|
52328-05-9 |
C2H6N2O |
详情 | 详情
|
(IV) |
41436 |
tert-butyl 2-[[amino(imino)methyl]amino]ethylcarbamate
|
|
C8H18N4O2 |
详情 |
详情
|
(V) |
41437 |
N-(2-aminoethyl)guanidine
|
|
C3H10N4 |
详情 |
详情
|
(VI) |
27852 |
1-methyl-4-nitro-1H-pyrrole-2-carbonyl chloride
|
|
C6H5ClN2O3 |
详情 |
详情
|
(VII) |
41445 |
N-(2-[[amino(imino)methyl]amino]ethyl)-1-methyl-4-nitro-1H-pyrrole-2-carboxamide
|
|
C9H14N6O3 |
详情 |
详情
|
(VIII) |
41446 |
4-amino-N-(2-[[amino(imino)methyl]amino]ethyl)-1-methyl-1H-pyrrole-2-carboxamide
|
|
C9H16N6O |
详情 |
详情
|
(IX) |
41447 |
N-(2-[[amino(imino)methyl]amino]ethyl)-1-methyl-4-[[(1-methyl-4-nitro-1H-pyrrol-2-yl)carbonyl]amino]-1H-pyrrole-2-carboxamide
|
|
C15H20N8O4 |
详情 |
详情
|
(X) |
41448 |
N-(2-[[amino(imino)methyl]amino]ethyl)-4-[[(4-amino-1-methyl-1H-pyrrol-2-yl)carbonyl]amino]-1-methyl-1H-pyrrole-2-carboxamide
|
|
C15H22N8O2 |
详情 |
详情
|
(XI) |
65171 |
1-methyl-4-nitro-1H-pyrrole-2-carbonyl chloride
|
28494-51-1 |
C6H5ClN2O3 |
详情 | 详情
|
(XII) |
41443 |
N-(2-[[amino(imino)methyl]amino]ethyl)-1-methyl-4-[[(1-methyl-4-[[(1-methyl-4-nitro-1H-pyrrol-2-yl)carbonyl]amino]-1H-pyrrol-2-yl)carbonyl]amino]-1H-pyrrole-2-carboxamide
|
|
C21H26N10O5 |
详情 |
详情
|
(XIII) |
61732 |
4-amino-N-(5-{[(5-{[(2-{[amino(imino)methyl]amino}ethyl)amino]carbonyl}-1-methyl-1H-pyrrol-3-yl)amino]carbonyl}-1-methyl-1H-pyrrol-3-yl)-1-methyl-1H-pyrrole-2-carboxamide
|
|
C21H28N10O3 |
详情 |
详情
|
(XIV) |
41441 |
4-[(2-bromoacryloyl)amino]-1-methyl-1H-pyrrole-2-carbonyl chloride
|
|
C9H8BrClN2O2 |
详情 |
详情
|
合成路线30
该中间体在本合成路线中的序号:
(I) The reaction of deuterium labeled ethylenediamine (I) with Boc2O in dioxane gives the monocarbamate (II), which is condensed with O-methylisourea (III) to yield the labeled aminoguanidine carbamate (IV). The cleavage of the carbamate group of (IV) by means of HCl in methanol affords the aminoguanidine (V), which is condensed with 1-methyl-4-nitropyrrole-2-carbonyl chloride (VI) by means of NaHCO3 in dioxane/water to provide the amide (VII). The reduction of the nitro group of (VII) by means of H2 over Pd/C in 1N HCl affords the 4-aminopyrrole-2-carboxamide (VIII), which is condensed with the acid chloride (VI) as before to give the diamide (IX). Reduction of the nitro group of (IX) under the same conditions described above yields the amino diamide (X), which is condensed with acid chloride (VI) as described above to afford the triamide (XI). Further reduction of the nitro group of (XI) gives the amino triamide (XII), which is finally condensed with 4-(2-bromopropenamido)-1-methylpyrrole-2-carbonyl chloride (XIII) by means of NaHCO3 in dioxane/water to yield the target deuterium labeled pentaamide compound.
【1】
Fontana, E.; Pignatti, A.; Synthesis of brostallicin (PNU-166196A) labelled with 2H and 14C. Label. Cop. & Radiopharm. 2002, 45, 11, 899.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(II) |
13241 |
N-Boc-ethylenediamine;tert-butyl (2-aminoethyl)carbamate;tert-butyl 2-aminoethylcarbamate; tert-Butyl n-(2-aminoethyl)carbamate |
57260-73-8 |
C7H16N2O2 |
详情 | 详情
|
(III) |
26657 |
O-methyl isourea; [Amino(imino)methoxy]methane
|
52328-05-9 |
C2H6N2O |
详情 | 详情
|
(IV) |
41436 |
tert-butyl 2-[[amino(imino)methyl]amino]ethylcarbamate
|
|
C8H18N4O2 |
详情 |
详情
|
(V) |
41437 |
N-(2-aminoethyl)guanidine
|
|
C3H10N4 |
详情 |
详情
|
(VI) |
27852 |
1-methyl-4-nitro-1H-pyrrole-2-carbonyl chloride
|
|
C6H5ClN2O3 |
详情 |
详情
|
(VII) |
41445 |
N-(2-[[amino(imino)methyl]amino]ethyl)-1-methyl-4-nitro-1H-pyrrole-2-carboxamide
|
|
C9H14N6O3 |
详情 |
详情
|
(VIII) |
41446 |
4-amino-N-(2-[[amino(imino)methyl]amino]ethyl)-1-methyl-1H-pyrrole-2-carboxamide
|
|
C9H16N6O |
详情 |
详情
|
(IX) |
41447 |
N-(2-[[amino(imino)methyl]amino]ethyl)-1-methyl-4-[[(1-methyl-4-nitro-1H-pyrrol-2-yl)carbonyl]amino]-1H-pyrrole-2-carboxamide
|
|
C15H20N8O4 |
详情 |
详情
|
(X) |
41448 |
N-(2-[[amino(imino)methyl]amino]ethyl)-4-[[(4-amino-1-methyl-1H-pyrrol-2-yl)carbonyl]amino]-1-methyl-1H-pyrrole-2-carboxamide
|
|
C15H22N8O2 |
详情 |
详情
|
(XI) |
41443 |
N-(2-[[amino(imino)methyl]amino]ethyl)-1-methyl-4-[[(1-methyl-4-[[(1-methyl-4-nitro-1H-pyrrol-2-yl)carbonyl]amino]-1H-pyrrol-2-yl)carbonyl]amino]-1H-pyrrole-2-carboxamide
|
|
C21H26N10O5 |
详情 |
详情
|
(XII) |
41444 |
N-(2-[[amino(imino)methyl]amino]ethyl)-4-[[(4-[[(4-amino-1-methyl-1H-pyrrol-2-yl)carbonyl]amino]-1-methyl-1H-pyrrol-2-yl)carbonyl]amino]-1-methyl-1H-pyrrole-2-carboxamide
|
|
C21H28N10O3 |
详情 |
详情
|
(XIII) |
41441 |
4-[(2-bromoacryloyl)amino]-1-methyl-1H-pyrrole-2-carbonyl chloride
|
|
C9H8BrClN2O2 |
详情 |
详情
|
合成路线31
该中间体在本合成路线中的序号:
(XVII) 3,4,5-Trimethoxyphenylacetic acid (IX) was alkylated with ethyl iodide in the presence of two equivalents of sodium bis(trimethylsilyl)amide to afford racemic trimethoxyphenylbutyric acid (X). After conversion to the corresponding acid chloride with SOCl2, condensation with (R)-4-benzyl-2-oxazolidinone (XI) in the presence of n-butyllithium gave N-acyloxazolidinone (XII) as a diastereomeric mixture that was separated by column chromatography. The required diastereoisomer was then hydrolyzed with lithium peroxide to provide (S)-2-(3,4,5-trimethoxyphenyl)butyric acid (XIII). Subsequent coupling of (XIII) with methyl (S)-pipecolate (XIV) employing 2-chloro-1-methylpyridinium iodide, followed by ester hydrolysis with LiOH, provided amide (XV). Further DCC-promoted coupling of (XV) to alcohol (VIII) provided (XVI). After acid cleavage of the tert-butyl ester, the resulting carboxylic acid was finally coupled to etylenediamine (XVII) in the presence of 1-benzotriazolyloxy tris(dimethylamino)phosphonium hexafluorophosphate to yield the title compound.
【1】
Yang, W.; Guo, T.; Keenan, T.P.; Laborde, E.; Holt, D.A. (Ariad Pharmaceuticals Inc.); Synthetic derivs. of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains. JP 2000505475; WO 9731898 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VIII) |
25348 |
tert-butyl 2-[3-[(1R)-3-(3,4-dimethoxyphenyl)-1-hydroxypropyl]phenoxy]acetate
|
|
C23H30O6 |
详情 |
详情
|
(IX) |
25349 |
2-(3,4,5-trimethoxyphenyl)acetic acid
|
937-52-0 |
C11H14O5 |
详情 | 详情
|
(X) |
25350 |
2-(3,4,5-trimethoxyphenyl)butyric acid
|
|
C13H18O5 |
详情 |
详情
|
(XI) |
25351 |
(4R)-4-benzyl-1,3-oxazolidin-2-one; (R)-(+)-4-benzyl-2-oxazolidinone
|
102029-44-7 |
C10H11NO2 |
详情 | 详情
|
(XII) |
25352 |
(4R)-4-benzyl-3-[2-(3,4,5-trimethoxyphenyl)butanoyl]-1,3-oxazolidin-2-one
|
|
C23H27NO6 |
详情 |
详情
|
(XIII) |
25353 |
(2S)-2-(3,4,5-trimethoxyphenyl)butyric acid
|
|
C13H18O5 |
详情 |
详情
|
(XIV) |
25354 |
methyl (2S)-2-piperidinecarboxylate
|
|
C7H13NO2 |
详情 |
详情
|
(XV) |
25355 |
(2S)-1-[(2S)-2-(3,4,5-trimethoxyphenyl)butanoyl]-2-piperidinecarboxylic acid
|
|
C19H27NO6 |
详情 |
详情
|
(XVI) |
25356 |
(1R)-1-[3-[2-(tert-butoxy)-2-oxoethoxy]phenyl]-3-(3,4-dimethoxyphenyl)propyl (2S)-1-[(2S)-2-(3,4,5-trimethoxyphenyl)butanoyl]-2-piperidinecarboxylate
|
|
C42H55NO11 |
详情 |
详情
|
(XVII) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
合成路线32
该中间体在本合成路线中的序号:
(XV) The reaction of 3,4-difluorobenzaldehyde (I) with methyl 4-methoxyacetoacetate (II) by means of piperidinium acetate in benzene gives the 3-benzylidene derivative (III), which is cyclized with O-methylisourea (IV) yielding dihydropyrimidine (V).
The optical resolution of dihydropyrimidine (V) can also be performed as follows: Dihydropyrimidine (V) is condensed with 4-nitrophenyl chloroformate (VI) by means of DMAP giving the 4-nitrophenyl ester (VII), which is treated with (R)-(+)-alpha-methylbenzylamine [(R)-MBA] yielding amide (VIII) as mixture of diastereomers that is separated by column chromatography. The (+) isomer was then treated with DBU in hot toluene to provide the dihydropyrimidine (+)(IX), already reported.
The intermediate 2-(trans-4-cyano-4-phenylcyclohexyl)ethylamine (XII) has been obtained by reductocondensation of 4-cyano-4-phenylcyclohexanone (XIII) with ethylenediamine (XIV) by means of p-toluenesulfonic acid and NaBH4 and separation of the isomers by careful chromatography.
【1】
Nagarathnam, D.; et al.; Design, synthesis and evaluation of dihydropyrimidinones as alpha-1A selective antagonists: 7. Modification of the piperidine moiety into 4-aminocyclohexane; identification and structure-activity relationship of SNAP 6991 analogs. 217th ACS Natl Meet (March 21 1999, Anaheim) 1999, Abst MEDI 110. |
【2】
Nagarathnam, D.; Wong, W.C.; Miao, S.W.; Patane, M.A.; Gluchowski, C. (Merck & Co., Inc.; Synaptic Pharmaceutical Corp.); Dihydropyrimidines and uses thereof. EP 0866708; JP 2000500470; WO 9717969 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26654 |
3,4-difluorobenzaldehyde
|
34036-07-2 |
C7H4F2O |
详情 | 详情
|
(II) |
26655 |
methyl 4-methoxy-3-oxobutanoate;Methyl 4-methoxyacetoacetate;Methyl 4-methoxy-3-oxo-butanoate |
41051-15-4 |
C6H10O4 |
详情 | 详情
|
(III) |
26656 |
methyl (Z)-3-(3,4-difluorophenyl)-2-(2-methoxyacetyl)-2-propenoate
|
|
C13H12F2O4 |
详情 |
详情
|
(IV) |
26657 |
O-methyl isourea; [Amino(imino)methoxy]methane
|
52328-05-9 |
C2H6N2O |
详情 | 详情
|
(V) |
26658 |
methyl 6-(3,4-difluorophenyl)-2-methoxy-4-(methoxymethyl)-1,6-dihydro-5-pyrimidinecarboxylate
|
|
C15H16F2N2O4 |
详情 |
详情
|
(VI) |
16605 |
4-Nitrophenyl chloroformate; 1-[(Chlorocarbonyl)oxy]-4-nitrobenzene
|
7693-46-1 |
C7H4ClNO4 |
详情 | 详情
|
(VII) |
26659 |
5-methyl 1-(4-nitrophenyl) 6-(3,4-difluorophenyl)-2-methoxy-4-(methoxymethyl)-1,5(6H)-pyrimidinedicarboxylate
|
|
C22H19F2N3O8 |
详情 |
详情
|
(VIII) |
26660 |
methyl 6-(3,4-difluorophenyl)-2-methoxy-4-(methoxymethyl)-1-[[(1-phenylethyl)amino]carbonyl]-1,6-dihydro-5-pyrimidinecarboxylate
|
|
C24H25F2N3O5 |
详情 |
详情
|
(IX) |
26658 |
methyl 6-(3,4-difluorophenyl)-2-methoxy-4-(methoxymethyl)-1,6-dihydro-5-pyrimidinecarboxylate
|
|
C15H16F2N2O4 |
详情 |
详情
|
(X) |
16606 |
Isobutyramide; 2-methylpropanamide
|
563-83-7 |
C4H9NO |
详情 | 详情
|
(XI) |
26659 |
5-methyl 1-(4-nitrophenyl) 6-(3,4-difluorophenyl)-2-methoxy-4-(methoxymethyl)-1,5(6H)-pyrimidinedicarboxylate
|
|
C22H19F2N3O8 |
详情 |
详情
|
(XII) |
26661 |
5-methyl 1-(4-nitrophenyl) 6-(3,4-difluorophenyl)-4-(methoxymethyl)-2-oxo-3,6-dihydro-1,5(2H)-pyrimidinedicarboxylate
|
|
C21H17F2N3O8 |
详情 |
详情
|
(XIII) |
26662 |
4-[(2-aminoethyl)amino]-1-phenylcyclohexanecarbonitrile
|
|
C15H21N3 |
详情 |
详情
|
(XIV) |
26663 |
4-oxo-1-phenylcyclohexanecarbonitrile
|
25115-74-6 |
C13H13NO |
详情 | 详情
|
(XV) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
合成路线33
该中间体在本合成路线中的序号:
(XV) The reaction of 3,4-difluorobenzaldehyde (I) with methyl 4-methoxyacetoacetate (II) by means of piperidinium acetate in benzene gives the 3-benzylidene derivative (III), which is cyclized with O-methylisourea (IV) yielding dihydropyrimidine (V). The optical resolution of (V) by chiral chromatography affords the (+)(IX) isomer, which is condensed with 4-nitrophenyl chloroformate (VI) by means of DMAP in dichloromethane giving the active 4-nitrophenyl ester (+)(X). The hydrolysis of the enol methyl ether of (X) with HCl in ether/dichloromethane yields the pyrimidinone (+)(XI), which is finally condensed with 2-(trans-4-cyano-4-phenylcyclohexyl)ethylamine (XII) in dichloromethane.
The intermediate 2-(trans-4-cyano-4-phenylcyclohexyl)ethylamine (XII) has been obtained by reductocondensation of 4-cyano-4-phenylcyclohexanone (XIII) with ethylenediamine (XIV) by means of p-toluenesulfonic acid and NaBH4 and separation of the isomers by careful chromatography.
【1】
Nagarathnam, D.; et al.; Design, synthesis and evaluation of dihydropyrimidinones as alpha-1A selective antagonists: 7. Modification of the piperidine moiety into 4-aminocyclohexane; identification and structure-activity relationship of SNAP 6991 analogs. 217th ACS Natl Meet (March 21 1999, Anaheim) 1999, Abst MEDI 110. |
【2】
Nagarathnam, D.; Wong, W.C.; Miao, S.W.; Patane, M.A.; Gluchowski, C. (Merck & Co., Inc.; Synaptic Pharmaceutical Corp.); Dihydropyrimidines and uses thereof. EP 0866708; JP 2000500470; WO 9717969 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26654 |
3,4-difluorobenzaldehyde
|
34036-07-2 |
C7H4F2O |
详情 | 详情
|
(II) |
26655 |
methyl 4-methoxy-3-oxobutanoate;Methyl 4-methoxyacetoacetate;Methyl 4-methoxy-3-oxo-butanoate |
41051-15-4 |
C6H10O4 |
详情 | 详情
|
(III) |
26656 |
methyl (Z)-3-(3,4-difluorophenyl)-2-(2-methoxyacetyl)-2-propenoate
|
|
C13H12F2O4 |
详情 |
详情
|
(IV) |
26657 |
O-methyl isourea; [Amino(imino)methoxy]methane
|
52328-05-9 |
C2H6N2O |
详情 | 详情
|
(V) |
26658 |
methyl 6-(3,4-difluorophenyl)-2-methoxy-4-(methoxymethyl)-1,6-dihydro-5-pyrimidinecarboxylate
|
|
C15H16F2N2O4 |
详情 |
详情
|
(IX) |
26658 |
methyl 6-(3,4-difluorophenyl)-2-methoxy-4-(methoxymethyl)-1,6-dihydro-5-pyrimidinecarboxylate
|
|
C15H16F2N2O4 |
详情 |
详情
|
(X) |
16606 |
Isobutyramide; 2-methylpropanamide
|
563-83-7 |
C4H9NO |
详情 | 详情
|
(XI) |
26659 |
5-methyl 1-(4-nitrophenyl) 6-(3,4-difluorophenyl)-2-methoxy-4-(methoxymethyl)-1,5(6H)-pyrimidinedicarboxylate
|
|
C22H19F2N3O8 |
详情 |
详情
|
(XII) |
26661 |
5-methyl 1-(4-nitrophenyl) 6-(3,4-difluorophenyl)-4-(methoxymethyl)-2-oxo-3,6-dihydro-1,5(2H)-pyrimidinedicarboxylate
|
|
C21H17F2N3O8 |
详情 |
详情
|
(XIII) |
26662 |
4-[(2-aminoethyl)amino]-1-phenylcyclohexanecarbonitrile
|
|
C15H21N3 |
详情 |
详情
|
(XIV) |
26663 |
4-oxo-1-phenylcyclohexanecarbonitrile
|
25115-74-6 |
C13H13NO |
详情 | 详情
|
(XV) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
合成路线34
该中间体在本合成路线中的序号:
(IV) Alkylation of ethyl piperazine-2-carboxylate (I) with two equivalents of isobutyl bromide (II) under catalysis of KI afforded disubstituted piperazine (III). The title imidazoline was then obtained by reaction of the ester function of (III) with ethylenediamine (IV) in the presence of trimethylaluminum.
【1】
Le Bihan, G.; et al.; Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 2. Syntheses and biological activities of 1,4-dialkyl-, 1,4-dibenzyl, and 1-benzyl-4-alkyl-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines an. J Med Chem 1999, 42, 9, 1587. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18343 |
ethyl 2-piperazinecarboxylate
|
89941-07-1 |
C7H14N2O2 |
详情 | 详情
|
(II) |
24599 |
1-bromo-2-methylpropane
|
78-77-3 |
C4H9Br |
详情 | 详情
|
(III) |
24600 |
ethyl 1,4-diisobutyl-2-piperazinecarboxylate
|
|
C15H30N2O2 |
详情 |
详情
|
(IV) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
合成路线35
该中间体在本合成路线中的序号:
(VII) The condensation of protected L-proline (I) with RINK RESIN (II) by means of TBTU, HOBT and DIEA in DMF gives the protected, rein bounded proline (III), which is deprotected by means of piperidine in DMF to yield the resin bounded proline (IV). The condensation of (IV) with 2-bromoacetic acid (V) by means of DIC in the same solvent affords the acyl proline (VI), which is treated with ethylene-1,2-diamine (VII) to provide the aminoacetyl proline (VIII). The condensation of (VIII) with 2-acetyldimedone (IX) gives the regioselectively monoprotected diaminoproline compound (X), which is treated with Boc2O and DIEA in dioxane to protect the secondary amino group of (X) and yield (XI). The selective elimination of the dimedone protecting group with hydrazine in DMF affords compound (XII) selectively monoprotected at the secondary amino group, which is condensed with 6-chloropyridine-3-carbonitrile (XIII) by means of DIEA in NMP to provide the resin adduct (XIV). The cleavage of the resin group of (XIV) by means of TFA and TFAA in dichloromethane takes place with simultaneous dehydration of the carboxamide group and removal of the Boc protecting group affording the trifluoroacetamido derivative (XV). Finally, the trifluoroacetyl group is removed by means of NH3 in aqueous methanol to give rise to the target pyridine carbonitrile derivative.
【1】
Willand, N.; et al.; Solid and solution phase syntheses of the 2-cyanopyrrolidide DPP-IV inhihitor NVP-DPP728. Tetrahedron 2002, 58, 28, 5741.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
34762 |
(2S)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]-2-pyrrolidinecarboxylic acid
|
71989-31-6 |
C20H19NO4 |
详情 | 详情
|
(III) |
42841 |
9H-fluoren-9-ylmethyl (2R)-2-(aminocarbonyl)-1-pyrrolidinecarboxylate
|
|
C20H20N2O3 |
详情 |
详情
|
(IV) |
36137 |
(2S)-2-pyrrolidinecarboxamide;L-prolinamide |
7531-52-4 |
C5H10N2O |
详情 | 详情
|
(V) |
23660 |
2-Bromoacetic acid
|
79-08-3 |
C2H3BrO2 |
详情 | 详情
|
(VI) |
54331 |
(2S)-1-(2-bromoacetyl)-2-pyrrolidinecarboxamide
|
n/a |
C7H11BrN2O2 |
详情 | 详情
|
(VII) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(VIII) |
57168 |
(2S)-1-{2-[(2-aminoethyl)amino]acetyl}-2-pyrrolidinecarboxamide
|
|
C9H18N4O2 |
详情 |
详情
|
(IX) |
57169 |
2-(1-hydroxyethylidene)-5,5-dimethyl-1,3-cyclohexanedione
|
|
C10H14O3 |
详情 |
详情
|
(X) |
57170 |
(2S)-1-{2-[(2-{[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]amino}ethyl)amino]acetyl}-2-pyrrolidinecarboxamide
|
|
C19H30N4O4 |
详情 |
详情
|
(XI) |
57171 |
tert-butyl 2-[(2S)-2-(aminocarbonyl)pyrrolidinyl]-2-oxoethyl(2-{[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]amino}ethyl)carbamate
|
|
C24H38N4O6 |
详情 |
详情
|
(XII) |
57172 |
tert-butyl 2-[(2S)-2-(aminocarbonyl)pyrrolidinyl]-2-oxoethyl(2-aminoethyl)carbamate
|
|
C14H26N4O4 |
详情 |
详情
|
(XIII) |
57164 |
2-Chloro-5-cyanopyridine; 6-Chloro-3-cyanopyridine; 6-Chloronicotinonitrile
|
33252-28-7 |
C6H3ClN2 |
详情 | 详情
|
(XIV) |
57173 |
tert-butyl 2-[(2S)-2-(aminocarbonyl)pyrrolidinyl]-2-oxoethyl{2-[(5-cyano-2-pyridinyl)amino]ethyl}carbamate
|
|
C20H28N6O4 |
详情 |
详情
|
(XV) |
57174 |
N-{2-[(5-cyano-2-pyridinyl)amino]ethyl}-N-{2-[(2S)-2-cyanopyrrolidinyl]-2-oxoethyl}-2,2,2-trifluoroacetamide
|
|
C17H17F3N6O2 |
详情 |
详情
|
合成路线36
该中间体在本合成路线中的序号:
(VI) The precursor bromoether (III) was prepared by condensation of 4,4’-difluorobenzhydrol (I) with 2-bromoethanol (II) under acidic conditions. Treatment of 4-bromocinnamic acid (IV) with thionyl chloride afforded acid chloride (V), which was coupled with ethylenediamine (VI) to furnish mono amide (VII). The title compound was finally obtained by alkylation of amine (VII) with bromide (III) in the presence of K2CO3.
【1】
Elmaleh, D.R.; Fischman, A.J.; Hanson, R.N.; Choi, S.-W.; Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy]ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors. J Med Chem 1999, 42, 18, 3647. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
41974 |
4,4'-Difluorobenzhydrol; bis(4-Fluorophenyl)methanol; alpha-(4-fluorophenyl)benzenemethanol; 4-fluoro-alpha-(4-fluorophenyl)benzenemethanol
|
365-24-2 |
C13H10F2O |
详情 | 详情
|
(II) |
10059 |
Ethylene bromohydrin; 2-Bromo-1-ethanol
|
540-51-2 |
C2H5BrO |
详情 | 详情
|
(III) |
41975 |
1-[(2-bromoethoxy)(4-fluorophenyl)methyl]-4-fluorobenzene; bis(4-fluorophenyl)methyl 2-bromoethyl ether
|
|
C15H13BrF2O |
详情 |
详情
|
(IV) |
41976 |
(E)-3-(4-bromophenyl)-2-propenoic acid
|
|
C9H7BrO2 |
详情 |
详情
|
(V) |
41977 |
(E)-3-(4-bromophenyl)-2-propenoyl chloride
|
|
C9H6BrClO |
详情 |
详情
|
(VI) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(VII) |
41978 |
(E)-N-(2-aminoethyl)-3-(4-bromophenyl)-2-propenamide
|
|
C11H13BrN2O |
详情 |
详情
|
合成路线37
该中间体在本合成路线中的序号:
(IV) The acetylation of clarithromycin (I) with acetic anhydride gives the diacetate (II), which is acylated with CDI yielding the 12-O-(imidazolylcarbonyl compound (III). The cyclization of (III) with ethylenediamine (IV) affords the cyclic carbamate (V), which is alkylated by reductocondensation with pyridine-3-carbaldehyde (VI) and NaBH(OAc)3 to give the secondary amine (VII). The methylation of this amine with formaldehyde and NaBH(OAc)3 yields the corresponding tertiary amine (VIII), which is treated with aqueous HCl to provide the descladinosyl compound (IX). Finally, this compound is acylated with 2-(2-pyridyl)acetic acid (X) by means of 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide (WSC), and deacetylated with methanol to afford the target compound.
【1】
Tanikawa, T.; Akashi, T.; Manaka, A.; Suzuki, K.; Asaka, T.; Adachi, T.; Ishii, T.; Sugiyama, H.; Kashimura, M.; Saito, H.; Morimoto, S.; Structure activity studies leading potent acyclides: 3-O-Acyl-5-O-desosaminylerythronolide 11,12-carbamates. 39th Intersci Conf Antimicrob Agents Chemother (Sept 26 1999, San Francisco) 1999, Abst F2159. |
【2】
Ishii, T.; Tanikawa, T.; Matsuura, A.; Sugimoto, T.; Asaka, T.; Kashimura, M. (Taisho Pharmaceutical Co., Ltd.); Erythromycin A derivs.. EP 0945459; WO 9823628 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
35358 |
|
|
C39H71NO12 |
详情 |
详情
|
(II) |
35359 |
|
|
C43H75NO14 |
详情 |
详情
|
(III) |
35360 |
|
|
C47H75N3O14 |
详情 |
详情
|
(IV) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(V) |
35361 |
|
|
C46H79N3O14 |
详情 |
详情
|
(VI) |
35374 |
5,6-dihydro-3-pyridinecarbaldehyde
|
|
C6H7NO |
详情 |
详情
|
(VII) |
35375 |
|
|
C52H84N4O14 |
详情 |
详情
|
(VIII) |
35376 |
|
|
C53H86N4O14 |
详情 |
详情
|
(IX) |
35377 |
|
|
C43H70N4O10 |
详情 |
详情
|
(X) |
35366 |
2-(2-pyridinyl)acetic acid
|
16179-97-8 |
C7H7NO2 |
详情 | 详情
|
合成路线38
该中间体在本合成路线中的序号:
(IV) The selective hydrolysis of clarithromycin (I) with aqueous HCl, followed by acylation with acetic anhydride gives the monoacetylated descladinosyl compound (XI), which by reaction with trichloromethyl chloroformate (TCF) yields the cyclic carbonate (XII). The reaction of (XII) with 1,1,3,3-tetramethylguanidine (TMG) affords intermediate (XIII), which is selecti-ely acylated with 2-(2-pyridyl)acetic acid (X) and WSC giving the 3-O-acylated compound (XIV). The activation of (XIV) with CDI affords the 12-O-imidazolylcarbonyl derivative (XV), which is cyclized with ethylenediamine (IV) providing the carbamate (XVI). The alkylation of the primary amine of (XVI) by reductocondensation with pyridine-3-carbaldehyde (VI) and NaBH(OAc)3 gives the secondary amine (XVII).
【1】
Tanikawa, T.; Akashi, T.; Manaka, A.; Suzuki, K.; Asaka, T.; Adachi, T.; Ishii, T.; Sugiyama, H.; Kashimura, M.; Saito, H.; Morimoto, S.; Structure activity studies leading potent acyclides: 3-O-Acyl-5-O-desosaminylerythronolide 11,12-carbamates. 39th Intersci Conf Antimicrob Agents Chemother (Sept 26 1999, San Francisco) 1999, Abst F2159. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
35358 |
|
|
C39H71NO12 |
详情 |
详情
|
(IV) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(VI) |
35374 |
5,6-dihydro-3-pyridinecarbaldehyde
|
|
C6H7NO |
详情 |
详情
|
(X) |
35369 |
(1R,2S,4R,6R)-2-(dimethylamino)-6-[[(3R,4S,5S,6R,7R,9R,13S,14R)-14-ethyl-4,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxooxa-11-cyclotetradecen-6-yl]oxy]-4-methylcyclohexyl acetate
|
|
C33H57NO9 |
详情 |
详情
|
(XI) |
35367 |
(1R,2S,4R,6R)-2-(dimethylamino)-6-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-4,12,13-trihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecanyl]oxy]-4-methylcyclohexyl acetate
|
|
C33H59NO10 |
详情 |
详情
|
(XII) |
35368 |
(1R,2R,4R,6S)-2-[[(3aR,4R,7R,8S,9S,10R,11R,13R,15R,15aR)-4-ethyl-8-hydroxy-11-methoxy-3a,7,9,11,13,15-hexamethyl-2,6,14-trioxododecahydro-4H-[1,3]dioxolo[4,5-c]oxacyclotetradecin-10-yl]oxy]-6-(dimethylamino)-4-methylcyclohexyl acetate
|
|
C34H57NO11 |
详情 |
详情
|
(XIII) |
35366 |
2-(2-pyridinyl)acetic acid
|
16179-97-8 |
C7H7NO2 |
详情 | 详情
|
(XIV) |
35370 |
(3R,4S,5R,6R,7R,9R,13S,14R)-6-[[(1R,2R,3S,5R)-2-(acetoxy)-3-(dimethylamino)-5-methylcyclohexyl]oxy]-14-ethyl-13-hydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxooxa-11-cyclotetradecen-4-yl 2-(2-pyridinyl)acetate
|
|
C40H62N2O10 |
详情 |
详情
|
(XV) |
35371 |
(2R,3S,7R,9R,10R,11R,12S,13R)-10-[[(1R,2R,3S,5R)-2-(acetoxy)-3-(dimethylamino)-5-methylcyclohexyl]oxy]-2-ethyl-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-12-[[2-(2-pyridinyl)acetyl]oxy]oxa-4-cyclotetradecen-3-yl 1H-imidazole-1-carboxylate
|
|
C44H64N4O11 |
详情 |
详情
|
(XVI) |
35372 |
|
|
C43H68N4O11 |
详情 |
详情
|
(XVII) |
35378 |
|
|
C49H73N5O11 |
详情 |
详情
|
合成路线39
该中间体在本合成路线中的序号:
(IV) The acetylation of clarithromycin (I) with acetic anhydride gives the diacetate (II), which is acylated with CDI yielding the 12-O-(imidazolylcarbonyl) compound (III). The cyclization of (III) with ethylenediamine (IV) affords the cyclic carbamate (V), which is alkylated by reductocondensation with quinoline-3-carbaldehyde (VI) and NaBH(OAc)3 to give the secondary amine (VII). The methylation of this amine with formaldehyde and NaBH(OAc)3 yields the corresponding tertiary amine (VIII), which is treated with aqueous HCl to provide the descladinosyl compound (IX). Finally, this compound is acylated with 2-(2-pyridyl)acetic acid (X) by means of 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide (WSC) and deacetylated with methanol to afford the target compound.
【1】
Tanikawa, T.; Akashi, T.; Manaka, A.; Suzuki, K.; Asaka, T.; Adachi, T.; Ishii, T.; Sugiyama, H.; Kashimura, M.; Saito, H.; Morimoto, S.; Structure activity studies leading potent acyclides: 3-O-Acyl-5-O-desosaminylerythronolide 11,12-carbamates. 39th Intersci Conf Antimicrob Agents Chemother (Sept 26 1999, San Francisco) 1999, Abst F2159. |
【2】
Ishii, T.; Tanikawa, T.; Matsuura, A.; Sugimoto, T.; Asaka, T.; Kashimura, M. (Taisho Pharmaceutical Co., Ltd.); Erythromycin A derivs.. EP 0945459; WO 9823628 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
35358 |
|
|
C39H71NO12 |
详情 |
详情
|
(II) |
35359 |
|
|
C43H75NO14 |
详情 |
详情
|
(III) |
35360 |
|
|
C47H75N3O14 |
详情 |
详情
|
(IV) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(V) |
35361 |
|
|
C46H79N3O14 |
详情 |
详情
|
(VI) |
35362 |
3-quinolinecarbaldehyde
|
13669-42-6 |
C10H7NO |
详情 | 详情
|
(VII) |
35363 |
|
|
C56H86N4O14 |
详情 |
详情
|
(VIII) |
35364 |
|
|
C57H88N4O14 |
详情 |
详情
|
(IX) |
35365 |
(1R,2R,4R,6S)-2-[((3aS,4R,7R,8S,9S,10R,11R,13R,15R,15aR)-4-ethyl-8-hydroxy-11-methoxy-3a,7,9,11,13,15-hexamethyl-1-[2-[methyl(3-quinolinylmethyl)amino]ethyl]-2,6,14-trioxotetradecahydro-2H-oxacyclotetradecino[4,3-d][1,3]oxazol-10-yl)oxy]-6-(dimethyl
|
|
C47H72N4O10 |
详情 |
详情
|
(X) |
35366 |
2-(2-pyridinyl)acetic acid
|
16179-97-8 |
C7H7NO2 |
详情 | 详情
|
合成路线40
该中间体在本合成路线中的序号:
(IV) The selective hydrolysis of clarithromycin (I) with aqueous HCl, followed by acylation with acetic anhydride gives the monoacetylated descladinosyl compound (XI), which by reaction with trichloromethyl chloroformate (TCF) yields the cyclic carbonate (XII). The reaction of (XII) with 1,1,3,3-tetramethylguanidine (TMG) affords intermediate (XIII), which is selectively acylated with 2-(2-pyridyl)acetic acid (X) and WSC giving the 3-O-acylated compound (XIV). The activation of (XIV) with CDI affords the 12-O-imidazolylcarbonyl derivative (XV), which is cyclized with ethylenediamine (IV) providing the carbamate (XVI). The alkylation of the primary amine of (XVI) by reductocondensation with quinoline-3-carbaldehyde (VI) and NaBH(OAc)3 gives the secondary amine (XVII).
【1】
Tanikawa, T.; Akashi, T.; Manaka, A.; Suzuki, K.; Asaka, T.; Adachi, T.; Ishii, T.; Sugiyama, H.; Kashimura, M.; Saito, H.; Morimoto, S.; Structure activity studies leading potent acyclides: 3-O-Acyl-5-O-desosaminylerythronolide 11,12-carbamates. 39th Intersci Conf Antimicrob Agents Chemother (Sept 26 1999, San Francisco) 1999, Abst F2159. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
35358 |
|
|
C39H71NO12 |
详情 |
详情
|
(IV) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(VI) |
35362 |
3-quinolinecarbaldehyde
|
13669-42-6 |
C10H7NO |
详情 | 详情
|
(X) |
35369 |
(1R,2S,4R,6R)-2-(dimethylamino)-6-[[(3R,4S,5S,6R,7R,9R,13S,14R)-14-ethyl-4,13-dihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxooxa-11-cyclotetradecen-6-yl]oxy]-4-methylcyclohexyl acetate
|
|
C33H57NO9 |
详情 |
详情
|
(XI) |
35367 |
(1R,2S,4R,6R)-2-(dimethylamino)-6-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-4,12,13-trihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecanyl]oxy]-4-methylcyclohexyl acetate
|
|
C33H59NO10 |
详情 |
详情
|
(XII) |
35368 |
(1R,2R,4R,6S)-2-[[(3aR,4R,7R,8S,9S,10R,11R,13R,15R,15aR)-4-ethyl-8-hydroxy-11-methoxy-3a,7,9,11,13,15-hexamethyl-2,6,14-trioxododecahydro-4H-[1,3]dioxolo[4,5-c]oxacyclotetradecin-10-yl]oxy]-6-(dimethylamino)-4-methylcyclohexyl acetate
|
|
C34H57NO11 |
详情 |
详情
|
(XIII) |
35366 |
2-(2-pyridinyl)acetic acid
|
16179-97-8 |
C7H7NO2 |
详情 | 详情
|
(XIV) |
35370 |
(3R,4S,5R,6R,7R,9R,13S,14R)-6-[[(1R,2R,3S,5R)-2-(acetoxy)-3-(dimethylamino)-5-methylcyclohexyl]oxy]-14-ethyl-13-hydroxy-7-methoxy-3,5,7,9,11,13-hexamethyl-2,10-dioxooxa-11-cyclotetradecen-4-yl 2-(2-pyridinyl)acetate
|
|
C40H62N2O10 |
详情 |
详情
|
(XV) |
35371 |
(2R,3S,7R,9R,10R,11R,12S,13R)-10-[[(1R,2R,3S,5R)-2-(acetoxy)-3-(dimethylamino)-5-methylcyclohexyl]oxy]-2-ethyl-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-12-[[2-(2-pyridinyl)acetyl]oxy]oxa-4-cyclotetradecen-3-yl 1H-imidazole-1-carboxylate
|
|
C44H64N4O11 |
详情 |
详情
|
(XVI) |
35372 |
|
|
C43H68N4O11 |
详情 |
详情
|
(XVII) |
35373 |
|
|
C53H75N5O11 |
详情 |
详情
|
合成路线41
该中间体在本合成路线中的序号:
(II) Condensation of the salicylaldehyde derivative (I) with ethylenediamine (II) affords the bis-imine (III). The title manganese complex is then obtained by treatment of (III) with manganese diacetate in ethanol.
【1】
Marcus, C.B.; Huffman, K.; Doctrow, S.R.; et al.; Salen-manganese complexes as catalytic scavengers of hydrogen peroxide and cytoprotective agents: structure-activity relationship studies. J Med Chem 2002, 45, 20, 4549.
|
【2】
Malfroy-Camine, B.; Doctrow, S.R. (Eukarion, Inc.); Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease. JP 1999507646; US 5696109; WO 9640148; WO 9640149 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
56984 |
3-ethoxy-2-hydroxybenzaldehyde
|
|
C9H10O3 |
详情 |
详情
|
(II) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(III) |
56985 |
2-ethoxy-6-{[(2-{[(E)-(3-ethoxy-2-hydroxyphenyl)methylidene]amino}ethyl)imino]methyl}phenol
|
|
C20H24N2O4 |
详情 |
详情
|
合成路线42
该中间体在本合成路线中的序号:
(VII) Reaction of 2-chloropyrazine (I) with 3,4-dichlorophenylmagnesium bromide (II) in the presence of [1,2-bis(diphenylphosphino)ethane]nickel(II) chloride produced the 2-arylpyrazine (III), which was reduced to the corresponding piperazine (IV) by means of DIBAL in THF. In a different procedure, bromination of methyl 3,4-dichlorophenylacetate (V) using N-bromosuccinimide, followed by reaction of the resulting bromo ester (VI) with ethylenediamine (VII) afforded the piperazinone (VIII), which was further reduced to (IV) by using LiAlH4 in Et2O.
【1】
Anthes, J.C.; McPhail, A.T.; Blythin, D.J.; Shue, H.-J.; Chen, X.; Piwinski, J.J.; shih, N.-Y.; Discovery of Sch 62373 and analogs, of novel series of 2-phenylpiperazines exhibiting potent dual NK1/NK2 antagonist activity. 221st ACS Natl Meet (April 1 2001, San Diego) 2001, Abst MEDI 244. |
【2】
Shue, H.-J.; Shih, N.-Y.; Blythin, D.J.; Chen, X.; Tom, W.C.; Piwinski, J.J.; McCormick, K.D. (Schering Corp.); Piperazino derivs. as neurokinin antagonists. EP 0823906; US 5719156; WO 9634864 .
|
【3】
Piwinski, J.J.; McCormick, K.D.; Shue, H.-J.; Chen, X.; Shih, N.-Y.; Blythin, D.J. (Schering Corp.); Piperazino derivs. as neurokinin antagonists. EP 0850236; JP 2000344766; US 5795894; US 5892039; WO 9708166 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
24075 |
2-chloropyrazine
|
14508-49-7 |
C4H3ClN2 |
详情 | 详情
|
(II) |
10069 |
Bromo(3,4-dichlorophenyl)magnesium
|
79175-35-2 |
C6H3BrCl2Mg |
详情 | 详情
|
(III) |
47945 |
2-(3,4-dichlorophenyl)pyrazine
|
|
C10H6Cl2N2 |
详情 |
详情
|
(IV) |
47946 |
2-(3,4-dichlorophenyl)piperazine
|
|
C10H12Cl2N2 |
详情 |
详情
|
(V) |
47947 |
methyl 2-(3,4-dichlorophenyl)acetate
|
|
C9H8Cl2O2 |
详情 |
详情
|
(VI) |
47948 |
methyl 2-bromo-2-(3,4-dichlorophenyl)acetate
|
|
C9H7BrCl2O2 |
详情 |
详情
|
(VII) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(VIII) |
47949 |
3-(3,4-dichlorophenyl)-2-piperazinone
|
|
C10H10Cl2N2O |
详情 |
详情
|
合成路线43
该中间体在本合成路线中的序号:
(II) The condensation of 1-(2-cyanophenoxy)-2,3-epoxypropane (I) with ethylenediamine (II) gives 1-(2-cyanophenoxy)-3-(2-aminoethylamino)-2-propanol (III), which is finally treated with phenyl isocyanate (IV) in acetonitrile.
【1】
Blancafort, P.; Serradell, M.N.; Castaner, J.; McGillion, F.B.; ICl-89,406. Drugs Fut 1981, 6, 9, 555.
|
【2】
Large, M.S.; Smith, L.H.; Beta-adrenergic blocking agents. 22. 1-Phenoxy-3-[[(substituted-amido)alkyl]amino]-2-propanols. J Med Chem 1982, 25, 11, 1286.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
37567 |
2-(2-oxiranylmethoxy)benzonitrile
|
|
C10H9NO2 |
详情 |
详情
|
(II) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(III) |
61094 |
2-{3-[(2-aminoethyl)amino]-2-hydroxypropoxy}benzonitrile
|
|
C12H17N3O2 |
详情 |
详情
|
(IV) |
11289 |
1-Isocyanatobenzene; phenyl isocyanate; Phenylisocyanate
|
103-71-9 |
C7H5NO |
详情 | 详情
|
合成路线44
该中间体在本合成路线中的序号:
(IX) The peroxidation of 1,4-diphenyl-1-cyclopentadiene (I) with O2, white light and activated by tetraphenylporphyrin in dichloromethane gives the peroxide (II), which is condensed with cyclohexane-1,4-dione (III) by means of trimethylsilyl trifluoromethanesulfonate in dichloromethane, yielding the adduct (IV). The reductocondensation of (IV) with N-(7-chloroquinolin-4-yl)ethylenediamine (V) by means of NaBH(OAc)3 in dichloromethane affords the tricyclic trioxane (VI), which is finally treated with citric acid in acetone to provide the target citrate.
The intermediate N-(7-chloroquinolin-4-yl)ethylenediamine (V) has been obtained by reaction of 4,7-dichloroquinoline (VIII) with ethylenediamine by means of NaOH at 85 C.
【1】
Dechy-Cabaret, O.; et al.; Preparation of antimalarial activities of "trioxaquines", new modular molecules with a trioxane skeleton linked to a 4-aminoquinoline. ChemBioChem 2000, 1, 4, 281.
|
【2】
Robert, A.; Dechy Cabaret, O.; Meunier, B.; Benoit Vical, F. (CNRS (Centre National de la Recherche Scientifique)); Dual molecules containing a peroxide deriv., synthesis and therapeutic applications thereof. FR 2807433; WO 0177105 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
51999 |
1-(4-phenyl-1,3-cyclopentadien-1-yl)benzene
|
|
C17H14 |
详情 |
详情
|
(II) |
52000 |
1,4-diphenyl-2,3-dioxabicyclo[2.2.1]hept-5-ene
|
|
C17H14O2 |
详情 |
详情
|
(III) |
52001 |
1,4-Cyclohexanedione; Tetrahydro-p-benzoquinone
|
637-88-7 |
C6H8O2 |
详情 | 详情
|
(IV) |
52002 |
|
|
C23H22O4 |
详情 |
详情
|
(V) |
52003 |
N(1)-(6-chloro-1-naphthyl)-1,2-ethanediamine; N-(2-aminoethyl)-N-(6-chloro-1-naphthyl)amine
|
|
C12H13ClN2 |
详情 |
详情
|
(VI) |
52004 |
|
|
C35H35ClN2O3 |
详情 |
详情
|
(VII) |
13856 |
2-Hydroxy-1,2,3-propanetricarboxylic acid; Citric acid
|
77-92-9 |
C6H8O7 |
详情 | 详情
|
(VIII) |
52005 |
1,6-dichloronaphthalene
|
|
C10H6Cl2 |
详情 |
详情
|
(IX) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
合成路线45
该中间体在本合成路线中的序号:
(II) The title imidazoline was synthesized by heating a solution of 2-fluoro-5-methylbenzonitrile (I) in ethylenediamine (II) in the presence of a catalytic amount of phosphorus pentasulfide.
【1】
Payard, M.; Danoun, S.; Baziard-Mouysset, G.; Anastassiadou, M.; Caignard, D.-H.; Renard, P.; Manechez, D.; Scalbert, E.; Rettori, M.-C. (ADIR et Cie.); New imidazoline derivs. having activity for the imidazoline receptor. EP 0846688; JP 1998168065; US 5925665 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
51374 |
2-Fluoro-5-methylbenzonitrile
|
|
C8H6FN |
详情 |
详情
|
(II) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
合成路线46
该中间体在本合成路线中的序号:
(VI) Condensation of 2-chloro-5-cyanopyridine (V) with ethylenediamine (VI) yields the N-pyridyl ethylenediamine (VII). Subsequent reaction of amine (VII) with pyrazole-1-carboxyamidine (VIII) in refluxing acetonitrile affords guanidine (IX). Finally, condensation between guanidine (IX) and enaminone (IV) in the presence of NaOEt produces the title pyrimidine derivative
【1】
Brown, S.P.; Goff, D.; Ring, D.B.; Harrison, S.D.; Subramanian, S.; Nuss, J.M.; Boyce, R.S.; Johnson, K.; Pfister, K.B.; Ramurthy, S.; Renhowe, P.A.; Seely, L.; Wagman, A.S.; Zhou, X.A. (Chiron Corp.); Inhibitors of glycogen synthase kinase 3. EP 1087963; US 6417185; WO 9965897 . |
【2】
Ring, D.B.; Harrison, S.D.; Nuss, J.M.; Boyce, R.S.; Johnson, K.; Pfister, K.B.; Ramurthy, S.; Seely, L.; Wagman, A.S.; Desai, M.; Levine, B.H. (Chiron Corp.); Inhibitors of glycogen synthase kinase 3. WO 0220495 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IV) |
60242 |
1-(2,4-dichlorophenyl)-3-(dimethylamino)-2-(4-methyl-1H-imidazol-2-yl)-2-propen-1-one
|
|
C15H15Cl2N3O |
详情 |
详情
|
(V) |
57164 |
2-Chloro-5-cyanopyridine; 6-Chloro-3-cyanopyridine; 6-Chloronicotinonitrile
|
33252-28-7 |
C6H3ClN2 |
详情 | 详情
|
(VI) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(VII) |
54332 |
6-[(2-aminoethyl)amino]nicotinonitrile
|
n/a |
C8H10N4 |
详情 | 详情
|
(VIII) |
15983 |
1H-pyrazole-1-carboximidamide
|
4023-00-1 |
C4H6N4 |
详情 | 详情
|
(IX) |
60243 |
N-{2-[(5-cyano-2-pyridinyl)amino]ethyl}guanidine
|
|
C9H12N6 |
详情 |
详情
|
合成路线47
该中间体在本合成路线中的序号:
(A) 4-Amiomoindan (I) is reacted with benzoylisothiocyanate (II) to give the benzoylthiourea (III), which after hydrolysis of 4-indanyltiourea (IV) is methylated with iodomethane to (V). The free base (VI) is cyclized with ethyldiamine (A) and p-toluenesulfonic acid to indanazoline
【1】
May, H. J.; Berg, A. (Nordmark-Werke GmbH); BE 786499; CA 967162; DE 2136325; FR 2146430; GB 1346037; JP 7319575; JP 7918260; NL 7209138; SA 7204747; SU 571502; US 3882229 .
|
【2】
Kirchhoff, T.; Kauff, N.D.; Mitra, N.; et al.; BRCA mutations and risk of prostate cancer in ashkenazi jews. Arzneim-Forsch Drug Res 1980, 30, 9, 1733.
|
【3】
Unterhalt, B.; Indanazoline Hydrochloride. Drugs Fut 1981, 6, 7, 417.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(I) |
60634 |
2,3-dihydro-1H-inden-4-ylamine; 4-indanamine
|
|
C9H11N |
详情 |
详情
|
(II) |
23530 |
benzoyl isothiocyanate
|
532-55-8 |
C8H5NOS |
详情 | 详情
|
(III) |
60636 |
N-benzoyl-N'-(2,3-dihydro-1H-inden-4-yl)thiourea
|
|
C17H16N2OS |
详情 |
详情
|
(IV) |
60637 |
N-(2,3-dihydro-1H-inden-4-yl)thiourea
|
|
C10H12N2S |
详情 |
详情
|
(V) |
60638 |
(2,3-dihydro-1H-inden-4-ylamino)(methylsulfanyl)methaniminium
|
|
C11H15N2S |
详情 |
详情
|
(VI) |
60639 |
4-{[imino(methylsulfanyl)methyl]amino}indane
|
|
C11H14N2S |
详情 |
详情
|
合成路线48
该中间体在本合成路线中的序号:
(IV) By reaction of 2-chloro-p-toluidine (I) with ammonium thiocyanide to give N-(2-chloro-p-tolyl)thiourea (II), which is then treated with methyl iodide in methanol to yield N-(2-chloro-p-tolyl)-S-methylisothiouronium iodide (III), which, without purification is condensed with ethylenediamine (IV) at 150-50 C.
【1】
Castaner, J.; Chatterjee, S.S.; Tolonidine. Drugs Fut 1976, 1, 5, 263.
|
【2】
(Boehringer Ingelheim GmbH.); GB 1034938 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
60741 |
2-chloro-4-methylaniline; 2-chloro-4-methylphenylamine
|
|
C7H8ClN |
详情 |
详情
|
(II) |
60740 |
N-(2-chloro-4-methylphenyl)thiourea
|
|
C8H9ClN2S |
详情 |
详情
|
(III) |
60742 |
|
|
C9H12ClIN2S |
详情 |
详情
|
(IV) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
合成路线49
该中间体在本合成路线中的序号:
(X) The reaction of 2,6-dichloro-4-methoxybenzyl chloride (I) with tetraethylammonium cyanide in refluxing dichloromethane gives 2-(2,6-dichloro-4-methoxyphenyl)acetonitrile (II), which is condensed with ethyl acetate (III) by means of sodium ethoxide in refluxing ethanol to yield the 3-oxobutyronitrile (IV). The cyclization of (IV) with hydrazine (V) by means of HOAc in refluxing benzene affords the aminopyrazole (VI), which is further cyclized with ethyl acetoacetate (VII) in refluxing acetic acid to provide 3-(2,6-dichloro-4-methoxyphenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-ol (VIII). The reaction of (VIII) with refluxing POCl3 furnishes the corresponding chloro derivative (IX), which is allowed to react with ethylenediamine (X) in hot acetonitrile to give 7-(2-aminoethylamino)-3-(2,6-dichloro-4-methoxyphenyl)-2,5-dimethylpyrazolo[1,5-a]pyrimidine (XI). Finally, this compound is reductocondensed with tetrahydropyran-4-one (XII) by means of sodium cyanoborohydride in methanol/HOAc to yield the target CP-671906-01.
【1】
Giangiordano, M.; Tran, J.; Darrow, J.W.; De Lombaert, S.; Blum, C.; Griffith, D.A.; Carpino, P.A. (Neurogen Corp.; Pfizer Inc.); Certain alkylene diamine-substd. pyrazolo[1,5-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines. US 6372743; WO 0123387 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
52615 |
3,5-dichloro-4-(chloromethyl)phenyl methyl ether; 1,3-dichloro-2-(chloromethyl)-5-(methyloxy)benzene
|
|
C8H7Cl3O |
详情 |
详情
|
(II) |
52616 |
2-[2,6-dichloro-4-(methyloxy)phenyl]acetonitrile
|
|
C9H7Cl2NO |
详情 |
详情
|
(III) |
17491 |
ethyl acetate
|
141-78-6 |
C4H8O2 |
详情 | 详情
|
(IV) |
52621 |
2-[2,6-dichloro-4-(methyloxy)phenyl]-3-oxobutanenitrile
|
|
C11H9Cl2NO2 |
详情 |
详情
|
(V) |
27344 |
hydrazine
|
302-01-2 |
H4N2 |
详情 | 详情
|
(VI) |
52617 |
4-[2,6-dichloro-4-(methyloxy)phenyl]-3-methyl-1H-pyrazol-5-amine; 4-[2,6-dichloro-4-(methyloxy)phenyl]-3-methyl-1H-pyrazol-5-ylamine
|
|
C11H11Cl2N3O |
详情 |
详情
|
(VII) |
11819 |
ethyl acetoacetate; ethyl 3-oxobutanoate;Acetoacetic ester;Ethyl beta-ketobutyrate;ethyl 3-oxobutyrate |
141-97-9 |
C6H10O3 |
详情 | 详情
|
(VIII) |
52618 |
3-[2,6-dichloro-4-(methyloxy)phenyl]-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-ol
|
|
C15H13Cl2N3O2 |
详情 |
详情
|
(IX) |
52619 |
7-chloro-3-[2,6-dichloro-4-(methyloxy)phenyl]-2,5-dimethylpyrazolo[1,5-a]pyrimidine; 3,5-dichloro-4-(7-chloro-2,5-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)phenyl methyl ether
|
|
C15H12Cl3N3O |
详情 |
详情
|
(X) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(XI) |
52620 |
N~1~-{3-[2,6-dichloro-4-(methyloxy)phenyl]-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-yl}-1,2-ethanediamine
|
|
C17H19Cl2N5O |
详情 |
详情
|
(XII) |
31563 |
tetrahydro-4H-pyran-4-one
|
29943-42-8 |
C5H8O2 |
详情 | 详情
|
合成路线50
该中间体在本合成路线中的序号:
(II) The title compound is prepared starting from the known (S) methyl 2-(biphenyl-2-yloxy)propionate (I). Treatment of ester (I) with ethylenediamine (II) in the presence of AlMe3 gives rise to the corresponding imidazoline (II) with some loss of optical purity. Enantiomeric enrichment of (II) is accomplished by fractional crystallization with (-)-di-O,O'-p-toluoyl-L-tartaric acid. The optically pure imidazoline is finally isolated as the corresponding oxalate salt.
【1】
Brasili, L.; Bousquet, P.; Gentili, F.; et al.; alpha-Adrenoceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole. J Med Chem 2002, 45, 1, 32.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IIIa) |
57629 |
2-[(1S)-1-([1,1'-biphenyl]-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole; [1,1'-biphenyl]-2-yl (1S)-1-(4,5-dihydro-1H-imidazol-2-yl)ethyl ether
|
|
C17H18N2O |
详情 |
详情
|
(IIIb) |
57630 |
2-[(1R)-1-([1,1'-biphenyl]-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole; [1,1'-biphenyl]-2-yl (1R)-1-(4,5-dihydro-1H-imidazol-2-yl)ethyl ether
|
|
C17H18N2O |
详情 |
详情
|
(I) |
57628 |
methyl (2S)-2-([1,1'-biphenyl]-2-yloxy)propanoate
|
|
C16H16O3 |
详情 |
详情
|
(II) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
合成路线51
该中间体在本合成路线中的序号:
(II) Reaction of methyl 6-nitroindole-2-carboxylate (I) with ethylenediamine (II) in hot DMF gives amino amide (III). After protection of (III) as the N-Boc derivative (IV), catalytic hydrogenation of its nitro group affords amine (V). Indole-2,5-dicarboxylic (VI) is activated as the bis-pentafluorophenyl ester (VII) by treatment with pentafluorophenyl trifluoroacetate. Subsequent coupling between the bis-pentafluorophenyl ester (VII) and amino indole (V) furnishes diamide (VIII). Removal of the N-Boc groups using trifluoroacetic acid in the presence of anisole produces diamine (IX).
【1】
Roberts, C.; et al.; Discovery af a new class of broad-spectrum antifungal compounds that target the minor groove of DNA. 28th Natl Med Chem Symp (June 8 2002, San Diego) 2002, Abst 67.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
56422 |
methyl 6-nitro-1H-indole-2-carboxylate
|
|
C10H8N2O4 |
详情 |
详情
|
(II) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(III) |
56423 |
N-(2-aminoethyl)-6-nitro-1H-indole-2-carboxamide
|
|
C11H12N4O3 |
详情 |
详情
|
(IV) |
56424 |
tert-butyl 2-{[(6-nitro-1H-indol-2-yl)carbonyl]amino}ethylcarbamate
|
|
C16H20N4O5 |
详情 |
详情
|
(V) |
56425 |
tert-butyl 2-{[(6-amino-1H-indol-2-yl)carbonyl]amino}ethylcarbamate
|
|
C16H22N4O3 |
详情 |
详情
|
(VI) |
56426 |
1H-indole-2,5-dicarboxylic acid
|
|
C10H7NO4 |
详情 |
详情
|
(VII) |
56427 |
bis(2,3,4,5,6-pentafluorophenyl) 1H-indole-2,5-dicarboxylate
|
|
C22H5F10NO4 |
详情 |
详情
|
(VIII) |
56428 |
tert-butyl 2-[({6-[({2-[({2-[({2-[(tert-butoxycarbonyl)amino]ethyl}amino)carbonyl]-1H-indol-6-yl}amino)carbonyl]-1H-indol-5-yl}carbonyl)amino]-1H-indol-2-yl}carbonyl)amino]ethylcarbamate
|
|
C42H47N9O8 |
详情 |
详情
|
(IX) |
56429 |
N~2~,N~5~-bis(2-{[(2-aminoethyl)amino]carbonyl}-1H-indol-6-yl)-1H-indole-2,5-dicarboxamide
|
|
C32H31N9O4 |
详情 |
详情
|
合成路线52
该中间体在本合成路线中的序号:
(II) Condensation of 1,8-naphthalic anhydride (I) with ethylenediamine (II) provides the N-aminoethyl naphthalimide (III). Amine (III) is subsequently condensed with 2-chloroethyl isocyanate (IV) to afford urea (V). Finally, nitrosation of (V) by means of NaNO2 and formic acid leads to the title N-nitrosourea.
【1】
Samanta, S.; et al.; Evaluation of naphthal-NU, a 2-chloroethylnitrosourea derivative of naphthalimide, as a mixed-function anticancer agent. J Exp Clin Cancer Res 2002, 21, 1, 87.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16982 |
1H,3H-benzo[de]isochromene-1,3-dione; 1,8-Naphthalic Anhydride
|
81-84-5 |
C12H6O3 |
详情 | 详情
|
(II) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(III) |
59030 |
2-(2-aminoethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione
|
|
C14H12N2O2 |
详情 |
详情
|
(IV) |
11237 |
1-Chloro-2-isocyanatoethane; 2-Chloroethyl isocyanate
|
1943-83-5 |
C3H4ClNO |
详情 | 详情
|
(V) |
59031 |
N-(2-chloroethyl)-N'-{2-[1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl]ethyl}urea
|
|
C17H16ClN3O3 |
详情 |
详情
|
合成路线53
该中间体在本合成路线中的序号:
(IV) Addition of benzylmagnesium bromide to 4-chlorobutyronitrile (II) gives rise to the chloro ketone adduct (III). Subsequent chloride displacement with ethylenediamine (IV) furnishes the target diamino ketone.
【1】
Andreadou, I.; Rekka, E.A.; Demopoulos, V.J.; Bijloo, G.J.; Kourounakis, P.N.; Synthesis, antioxidant and anti-inflammatory activity of novel substituted ethylenediamines and ethanolamines. A preliminary quantitative structure-activity relationship study. Arzneim-Forsch Drug Res 1997, 47, 5, 643. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
28308 |
benzyl(bromo)magnesium; benzylmagnesium bromide
|
1589-82-8 |
C7H7BrMg |
详情 | 详情
|
(II) |
11179 |
4-Chlorobutanenitrile; 4-Chlorobutyronitrile
|
628-20-6 |
C4H6ClN |
详情 | 详情
|
(III) |
64973 |
5-chloro-1-phenyl-2-pentanone
|
|
C11H13ClO |
详情 |
详情
|
(IV) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
合成路线54
该中间体在本合成路线中的序号:
(XVIII) A different protection strategy involves masking the ring nitrogens as amide groups. Methyl acrylate (XVII) is reacted with neat ethylenediamine (XVIII) to yield the aminopropionamide derivative (XIX), which is then cyclized with dimethyl malonate (XX), producing the trioxocyclam (XXI). After condensation of (XXI) with p-dibromoxylene (IIIa), the resulting hexaoxo bis-cyclam (XXII) is reduced to the title compound employing borane-dimethyl sulfide complex in refluxing THF (10). Alternatively, protection of the linear tetraamine (XXIII) with pyruvic aldehyde (XXIV) generates the tricyclic bisaminal (XXV) along with its minor isomer (XXVI). The crude mixture of bis-aminals (XXV) and (XXVI) is then cyclized to (XXVIII) with 1,3-dibromopropane (XXVII) and K2CO3. After condensation of (XXVIII) with dibromide (IIIa), the resulting bis-ammonium dimer (XXIX) is hydrolyzed to the title compound upon heating with 3M NaOH (11). Scheme 3.
【10】
Achmatowicz, M., Hegedus, L.S. Direct synthesis of 1,1’-[1,4-phenylenebis(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane octahydrochloride (AMD 3100) without the use of protecting groups. J Org Chem 2003, 68(16): 6435-6. |
【11】
Boschetti, F., Denat, F., Espinosa, E., Tabard, A., Dory, Y., Guilard, R. Regioselective N-functionalization of tetraazacycloalkanes. J Org Chem 2005, 70(18): 7042-53. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IIIa) |
18697 |
1,4-bis(bromomethyl)benzene
|
623-24-5 |
C8H8Br2 |
详情 | 详情
|
(XVII) |
14156 |
methyl acrylate
|
96-33-3 |
C4H6O2 |
详情 | 详情
|
(XVIII) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(XIX) |
65221 |
|
|
C7H18N4O |
详情 | 详情
|
(XX) |
19373 |
dimethyl malonate;Methyl malonate;Propanedioic acid dimethyl ester |
108-59-8 |
C5H8O4 |
详情 | 详情
|
(XXI) |
65222 |
|
|
C10H18N4O3 |
详情 | 详情
|
(XXII) |
65223 |
|
|
C28H42N8O6 |
详情 | 详情
|
(XXIII) |
53968 |
1,4,8,11-Tetraazaundecane; 3,7-Diaza-1,9-nonanediamine; N,N'-Bis(2-aminoethyl)-1,3-propanediamine; N,N[-Bis(2-aminoethyl)-1,3-propanediamine
|
4741-99-5 |
C7H20N4 |
详情 | 详情
|
(XXIV) |
25598 |
2-oxopropanal
|
78-98-8 |
C3H4O2 |
详情 | 详情
|
(XXV) |
65224 |
|
|
C10H20N4 |
详情 | 详情
|
(XXVI) |
65225 |
|
|
C10H20N4 |
详情 | 详情
|
(XXVII) |
12581 |
1,3-Dibromopropane
|
109-64-8 |
C3H6Br2 |
详情 | 详情
|
(XXVIII) |
65526 |
|
|
C26H37O7P |
详情 | 详情
|
(XXIX) |
65227 |
|
|
C34H54Br2N8 |
详情 | 详情
|
合成路线55
该中间体在本合成路线中的序号:
(IX) In an adapted method, complete solution-phase synthesis of SQ-109 is achieved by the substitution of (2E)-1-bromo-3,7-dimethylocta-2,6-diene (VIII) by ethylene diamine (IX) at –78 °C in dry DCM to give (E)-N’-(3,7-dimethylocta-2,6-dienyl)ethane-1,2-diamine (X) (4, 5). Finally, amine (X) is made to undergo reductive amination with 2-adamantanone (XI) in MeOH using NaBH4 under an N2 atmosphere overnight to give SQ-109, which can be extracted with ethyl acetate or converted to a hydrochloride salt using HCl and MeOH. Scheme 2.
【4】
Onajole, O.K., Govender, P., van Helden, P.D., Kruger, H.G., Maguire, G.E., Wiid, I., Govender, T. Synthesis and evaluation of SQ109 analogues as potential anti-tuberculosis candidates. Eur J Med Chem 2010, 45(5): 2075-9. |
【5】
Onajole, O.K., Sosibo, S., Govender, P. et al. Novel linear diamine disubstituted polycyclic ‘cage’ derivatives as potential antimycobacterial candidates. Chem Biol Drug Design 2011, 78(6): 1022-30. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VIII) |
31116 |
(2E)-1-bromo-3,7-dimethyl-2,6-octadiene; trans-Geranyl bromide; Geranyl bromide |
6138-90-5 |
C10H17Br |
详情 | 详情
|
(IX) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(X) |
66063 |
(E)-N’-(3,7-dimethylocta-2,6-dienyl)ethane-1,2-diamine |
|
C12H24N2 |
详情 | 详情
|
(XI) |
40404 |
2-adamantanone
|
700-58-3 |
C10H14O |
详情 | 详情
|
合成路线56
该中间体在本合成路线中的序号:
(VIII)
【1】
Jin QW, Mnuragis MA, May PD. 2003. Process for preparing aminocarbonylpyrrolylmethylideneindolinones from indolinones, imidazolcarbonylpyrrolecarboxaldehydes, and amines. W0 2003070725 |
【2】
Manley JM, Kalman MJ, Conway BG, et al. 2003. Early amidation approach to 3-[(4-anudo)pyrrol-2-yl]-2-indolinones. J Org Cbem, 68(16):6447~6450 |
【3】
Sun L, Liang C, Shirazian S, et aL. 2003. Discovery of 5-[5-Fluoro-2-oxo-l,2-dihydroindol-(3Z)-ylidenemethyl}2,4一dimethyl-lH-pyrrole-3-carboxylic acid (2-diethylaminoethyl) amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase. J Med Chem, 46(7): 1116~1119 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
63353 |
1,1-dimethylethyl 2-(hydroxyimino)-3-oxobutanoate
|
14352-65-9 |
C8H13NO4 |
详情 | 详情
|
(VIII) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(IX) |
66753 |
(E)-N-(2-(diethylamino)ethyl)-5-(((2-(diethylamino)ethyl)imino)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide |
|
C20H37N5O |
详情 | 详情
|
(X) |
60384 |
5-fluoro-1,3-dihydro-2H-indol-2-one
|
56341-41-4 |
C8H6FNO |
详情 | 详情
|
(XI) |
66752 |
(Z)-N-[2-(Diethylamino)ethyl]-5-(5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide |
326914-13-0 |
C22H27FN4O2 |
详情 | 详情
|
(I) |
27907 |
Acetoacetic acid tert-butyl ester;3-Oxo-butanoic acid 1,1-dimethylethyl estertert-butyl 3-oxobutanoate |
1694-31-1 |
C8H14O3 |
详情 | 详情
|
(III) |
11819 |
ethyl acetoacetate; ethyl 3-oxobutanoate;Acetoacetic ester;Ethyl beta-ketobutyrate;ethyl 3-oxobutyrate |
141-97-9 |
C6H10O3 |
详情 | 详情
|
(IV) |
63354 |
2-(1,1-dimethylethyl) 4-ethyl 3,5-dimethyl-1H-pyrrole-2,4-dicarboxylate
|
86770-31-2 |
C14H21NO4 |
详情 | 详情
|
(V) |
60380 |
ethyl 2,4-dimethyl-1H-pyrrole-3-carboxylate
|
2199-51-1 |
C9H13NO2 |
详情 | 详情
|
(VI) |
60381 |
ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate
|
2199-59-9 |
C10H13NO3 |
详情 | 详情
|
(VII) |
60382 |
5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid
|
253870-02-9 |
C8H9NO3 |
详情 | 详情
|
合成路线57
该中间体在本合成路线中的序号:
(VII) Nitration of vanillin acetate (I) by means of HNO3 yields the 2-nitrobenzaldehyde derivative (II), which by hydrolysis of the acetate ester with K2CO3 in MeOH provides 2-nitrovanillin (III). Protection of phenol (III) by means of benzyl bromide and K2CO3 in DMF gives the corresponding benzyl ether (IV), which by reaction of the aldehyde moiety with iodine and excess NH3 in H2O/THF results in nitrile (V). Reduction of the nitro group in compound (V) using Fe and AcOH, followed by cyclization of the resulting aminonitrile (VI) with ethylenediamine (VII) in the presence of sulfur affords imidazoline (VIII). Subsequent ring closure of the aminoimidazoline derivative (VIII) with cyanogen bromide (IX) by means of Et3N in CH2Cl2 yields the imidazo[1,2-c] quinazoline derivative (X), which is then debenzylated by means of TFA to give the corresponding phenol (XI). Alkylation of phenol (XI) with 4-(3-chloropropyl)morpholine (XII) in the presence of Cs2CO3 in DMF affords the morpholinopropyl ether (XIII) (1), which is finally condensed with 2-aminopyrimidine-5-carboxylic acid (XIV) using PyBOP and DIEA in DMF .
2-Aminopyrimidine-5-carboxylic acid (XIV) is prepared by cyclization of sodium 2-(dimethoxymethyl)-3-methoxy-3-oxoprop-1(Z)-en-1-olate (XV) with guanidine hydrochloride (XVI) to provide methyl 2-aminopyrimidine-5-carboxylate (XVII), which is then hydrolyzed with LiOH in MeOH .
【1】
Scott, W.J., Hentemann, S.M., Rowley, B. et al. Novel 2,3-dihydroimidazo[1,2-c]quinazolines PI3K inhibitors: Discovery and SAR. 22nd EORTCNCI-AACR Symp Mol Targets Cancer Ther (Nov 16-19, Berlin) 2010, Abst 444. |
【2】
Hentemann, M., Wood, J., Scott, W. et al. (Bayer Pharmaceuticals Corp.). Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis. EP 2096919, JP 2010511718, US 2011083984, US 8466283, US 201326113, WO 2008070150. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XI) |
68135 |
5-amino-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-8-ol bis(2,2,2-trifluoroacetate) |
|
C11H12N4O2.2C2HF3O2 |
详情 | 详情
|
(I) |
68127 |
vanillin acetate;4-Acetoxy-3-methoxybenzaldehyde;4-Formyl-2-methoxyphenyl acetate |
881-68-5 |
C10H10O4 |
详情 | 详情
|
(II) |
68128 |
4-formyl-2-methoxy-3-nitrophenyl acetate;4-O-Acetyl-2-nitrovanillin;4-(acetyloxy)-3-methoxy-2-nitro-Benzaldehyde |
2698-69-3 |
C10H9NO6 |
详情 | 详情
|
(III) |
68129 |
2-nitrovanillin;4-Hydroxy-3-methoxy-2-nitrobenzaldehyde |
|
C8H7NO5 |
详情 | 详情
|
(IV) |
68130 |
4-(benzyloxy)-3-methoxy-2-nitrobenzaldehyde |
|
C15H13NO5 |
详情 | 详情
|
(V) |
68131 |
4-(benzyloxy)-3-methoxy-2-nitrobenzonitrile |
|
C15H12N2O4 |
详情 | 详情
|
(VI) |
68132 |
2-amino-4-(benzyloxy)-3-methoxybenzonitrile |
|
C15H14N2O2 |
详情 | 详情
|
(VII) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(VIII) |
68133 |
3-(benzyloxy)-6-(4,5-dihydro-1H-imidazol-2-yl)-2-methoxyaniline |
|
C17H19N3O2 |
详情 | 详情
|
(IX) |
28017 |
cyanic bromide;cyanogen bromide |
506-68-3 |
CBrN |
详情 | 详情
|
(X) |
68134 |
8-(benzyloxy)-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-amine |
|
C18H18N4O2 |
详情 | 详情
|
(XIII) |
68137 |
7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-amine |
|
C18H25N5O3 |
详情 | 详情
|
(XIV) |
68136 |
2-aminopyrimidine-5-carboxylic acid;2-Amino-5-carboxypyrimidine;2-Amino-5-pyrimidinecarboxylic acid |
3167-50-8 |
C5H5N3O2 |
详情 | 详情
|
(XV) |
68138 |
sodium (Z)-2-(dimethoxymethyl)-3-methoxy-3-oxoprop-1-en-1-olate |
|
C7H11NaO5 |
详情 | 详情
|
(XVI) |
14262 |
Guanidine hydrochloride
|
50-01-1 |
CH5N3.HCl |
详情 | 详情
|
(XVII) |
68139 |
methyl 2-aminopyrimidine-5-carboxylate |
308348-93-8 |
C6H7N3O2 |
详情 | 详情
|
合成路线58
该中间体在本合成路线中的序号:
(VII) Reaction of 2-nitrovanillin (III) with NH4OH and I2 in H2O/THF yields nitrile (XVIII), which is then condensed with 4-(3-chloropropyl)morpholine hydrochloride (XII) —prepared by alkylation of morpholine (XIX) with 1-bromo-3-chloropropane (XX) in toluene at 84 °C— by means of Cs2CO3 in DMF at 75 °C to give the morpholinopropyl ether (XXI). Reduction of the nitro group in compound (XXI) with Fe and AcOH affords amine (XXII), which by cyclization with ethylenediamine (VII) and sulfur at 100 °C produces the imidazoline derivative (XXIII). Finally, aminoimidazoline (XXIII) is then subjected to ring closure with cyanogen bromide (IX) in the presence of Et3N in CH2Cl2 .
【1】
Hentemann, M., Wood, J., Scott, W. et al. (Bayer Pharmaceuticals Corp.). Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis. EP 2096919, JP 2010511718, US 2011083984, US 8466283, US 201326113, WO 2008070150. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III) |
68129 |
2-nitrovanillin;4-Hydroxy-3-methoxy-2-nitrobenzaldehyde |
|
C8H7NO5 |
详情 | 详情
|
(VII) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
(IX) |
28017 |
cyanic bromide;cyanogen bromide |
506-68-3 |
CBrN |
详情 | 详情
|
(XII) |
18691 |
4-(3-chloropropyl)morpholine;N-(3-Chloropropyl)morpholine |
7357-67-7 |
C7H14ClNO |
详情 | 详情
|
(XIII) |
68137 |
7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-amine |
|
C18H25N5O3 |
详情 | 详情
|
(XVIII) |
68140 |
4-hydroxy-3-methoxy-2-nitrobenzonitrile |
|
C8H6N2O4 |
详情 | 详情
|
(XIX) |
10388 |
Morpholine
|
110-91-8 |
C4H9NO |
详情 | 详情
|
(XX) |
10358 |
1-Bromo-3-chloropropane
|
109-70-6 |
C3H6BrCl |
详情 | 详情
|
(XXI) |
66434 |
4-methoxy-5-(3-morpholinopropoxy)-2-nitrobenzonitrile |
675126-26-8 |
C15H19N3O5 |
详情 | 详情
|
(XXII) |
66435 |
2-amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile |
675126-27-9 |
C15H21N3O3 |
详情 | 详情
|
(XXIII) |
68141 |
6-(4,5-dihydro-1H-imidazol-2-yl)-2-methoxy-3-(3-morpholinopropoxy)aniline |
|
C17H26N4O3 |
详情 | 详情
|
合成路线59
该中间体在本合成路线中的序号:
(VI) GMI-1070 is prepared by condensation of 8-amino-1,3,6-naphthalenetrisulfonic acid (I) with ethylene bis(glycolic acid) (II) by means of HATU and DIEA in DMF to afford the mono amide (III), which is finally coupled with the primary amine (IV) [prepared by condensation of methyl ester (V) with ethylenediamine (VI) at 70°C] by means of HATU and DIEA in DMF .
【1】
Magnani, J.L., Patton, J.T. Jr., Sarkar, A.K., Svarovsky, S.A., Ernst, B. (GlycoMimetics, Inc.). Heterobifunctional pan-selectin inhibitors. EP 1934236, EP 2264043, JP 2009507031, US 2007054870, US 7728117, WO 2007028050. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
68483 |
8-amino-1,3,6-naphthalenetrisulfonic acid;1-Aminonaphthalene-3,6,8-trisulfonic acid |
117-42-0 |
C10H9NO9S3 |
详情 | 详情
|
(II) |
68484 |
2,2'-(ethane-1,2-diylbis(oxy))diacetic acid;2,2'-[1,2-ethanediylbis(oxy)]bis-Acetic acid;(Ethylenedioxy)diacetic acid;1,2-Bis(carboxymethoxy)ethane;2,5-Dioxa-1,6-hexanedicarboxylic acid;3,6-Dioxaoctane-1,8-dioic acid;3,6-Dioxaoctanedioic acid;Ethylenebis(glycolic acid);[2-(Carboxymethoxy)ethoxy]acetic acid |
23243-68-7 |
C6H10O6 |
详情 | 详情
|
(III) |
68485 |
2-(2-(2-oxo-2-((3,6,8-trisulfonaphthalen-1-yl)amino)ethoxy)ethoxy)acetic acid |
|
C16H17NO14S3 |
详情 | 详情
|
(IV) |
68487 |
|
|
C42H59N5O18 |
详情 | 详情
|
(V) |
68486 |
(2R)-2-(((2S,3S,4R,5R,6S)-2-(((1S,3R,5S)-5-((2-aminoethyl)carbamoyl)-3-(2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxamido)-2-(((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)cyclohexyl)oxy)-3-(benzoyloxy)-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)oxy)-3-cyclohexylpropanoic acid |
|
C41H55N3O19 |
详情 | 详情
|
(VI) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|
合成路线60
该中间体在本合成路线中的序号:
(III)
【1】
Kim DK.N-(b-mercapto-iso-butyryl)proline,derivatives and a process for their preparation:DE,Patent 3,538,747,1986. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
69583 |
(S)-1-((S)-3-chloro-2-methylpropanoyl)pyrrolidine-2-carboxylic acid |
|
C9H14ClNO3 |
详情 |
详情
|
(II) |
69592 |
(S)-1-((S)-3-((ethoxycarbonothioyl)thio)-2-methylpropanoyl)pyrrolidine-2-carboxylic acid |
|
C12H19NO4S2 |
详情 |
详情
|
(III) |
14754 |
ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine |
107-15-3 |
C2H8N2 |
详情 | 详情
|